Zusammenfassung
» Die Pflege eines Sterbenden muss zuallererst seine physischen Bedürfnisse berücksichtigen (Kübler-Roos 2000) «
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur: Einleitung
Collins LM, Sayer AG (2000) Modeling growth and change process. In: Reis HT, Judd CM (Hrsg) Handbook of research methods in social and personality psychology. University Press, Cambridge; pp 478–95
Dangel T (2001) Domowa opieka paliatywna nad dziecmi w Polsce. Department of Palliative Care – Institute for Mother and Child, Warsaw
Drake R, Frost J, Collins JJ (2003) The symptoms of dying children. J Pain Symptom Manage 26:594–603
Feudtner C, Kang TI, Hexem KR, Friedrichsdorf SJ, Osenga K, Siden H et al. (2011) Pediatric Palliative Care Patients: A Prospective Multicenter Cohort Study. Pediatr 127:1094–101
Goldman A, Chir B (2000) Symptoms and suffering at the end of life in children with cancer [Letter to the editor]. N Engl J Med 342:1998–9
Hechler T, Blankenburg M, Friedrichsdorf S, Garske D, Hübner B, Menke A et al. (2008) Parents‘ perspective on symptoms, quality of life, characteristics of death and end-oflife decisions for children dying from cancer. Klin Pädiatr 220:166–74
Hongo T, Watanabe C, Okada S, Inoue N, Yajima S, Fujii Y et al. (2003) Analysis of the circumstances at the end of life in children with cancer: symptoms, suffering and acceptance. Pediatr Int 45:60–4
Kübler-Ross E (2000) Kinder und Tod. Knaur, Stuttgart
Landesinitiative NRW zur Erforschung der Palliativversorgung von Kindern und Jugendlichen (2009) Ambulante Palliativversorgung von Kindern und Jugendlichen. Abschlussbericht der Begleitforschung zur nordrhein-westfälischen Landesinitiative. http://www.services nordrheinwestfalendirekt de/broschuerenservice/download/70605/gesamtbericht_ambulante_palliativversorgung.pdf. Abgerufen 07.04.2012
Pritchard M, Burghen E, Srivastava DK, Okuma J, Anderson L, Powell B et al. (2008) Cancer-Related Symptoms Most Concerning to Parents During the Last Week and Last Day of Their Child’s Life. Pediatr 121:e1301-e1309
Theunissen JM, Hoogerbrugge PM, van Achterberg T, Prins JB, Vernooij-Dassen MJ, van den Ende CH (2007) Symptoms in the palliative phase of children with cancer. Pediatr Blood Cancer 49:160–5
Tietze AL, Zernikow B, Blankenburg M (2012) Komplex neurologisch erkrankte Kinder: Entwicklung und Validierung eines Fragebogens zur Erhebung schlafstörungsbedingter Belastungen bei Eltern. In preparation
Von Lützau P, Otto M, Hechler T, Metzing S, Wolfe J, Zernikow B (2012) Children dying from cancer: parents’ perspectives on symptoms, quality of life, characteristics of death and end-of-life decisions. J Palliat Care submitted
WHO (1998) Obesity: Preventing and managing the global epidemic. Report on a WHO consultation on obesity, Geneva 3–5 June 1997, WHO/NUT/NCD/98.1, Geneva
WHO (2012) WHO Guidelines on the pharmacological treatment of persistent pain in children with medical illnesses. WHO Press, Geneva, Switzerland. http://apps.who.int/medicinedocs/documents/s19116en/s19116en.pdf. Abgerufen 04.04.2012
Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S et al. (2000) Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342:326–33
Zernikow B (1999) Schmerz-Therapie in der onkologischen Pädiatrie (STOP). Schmerz 13:208–9
http://www.eigenes-leben-ev.de. Abgerufen 17.03.2012
Zu Abschnitt 6.1: Abschnitt 6.1.1
Bellomo-Brandao MA, Collares EF, da-Costa-Pinto EAL (2003) Use of erythromycin for the treatment of severe chronic constipation in children. Braz J Med Biol Res 36:1391–6
Candy B, Jones L, Goodman ML, Drake R, Tookman A (2011) Laxatives or methylnaltrexone for the management of constipation in palliative care patients. Cochrane Database Syst Rev:CD003448
Claßen M (2011) Obstipation. Pädiatrie up2date 6:247–68
Clemens KE, Klaschik E (2008) Management of constipation in palliative care patients. Curr Opin Support Palliat Care 2:22–7
Deibert P, Xander C, Blum HE, Becker G (2009) Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation. Core evidence 4:247–58
Gremse DA, Hixon J, Crutchfield A (2002) Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children. Clin Pediatr (Phila) 41:225–9
Jassal SS (2011) Basic symptom control in paediatric palliative care. The Rainbow Children’s Hospice Guidelines. ACT, Bristol
Keller KM (2002) Evidenzbasierte Therapie der chronischen Obstipation und Enkopresis bei Kindern. Monatsschr Kinderheilkd 150:594–601
Phillips RS, Gibson F (2008) A systematic review of treatments for constipation in children and young adults undergoing cancer treatment. J Pediatr Hematol Oncol 30:829–30
Tolia V, Lin CH, Sur Y (1993) A prospective randomized study with mineral oil and oral lavage solution for treatment of faecal impaction in children. Aliment Pharmacol Ther 7:523–9
Abschnitt 6.1.2
Blake P, Delicata R, Cross N, Sturgeon G, Hargest R (2012) Large bowel obstruction due to colorectal carcinoma can be safely treated by colonic stent insertion – case series from a UK district general hospital. Colorectal Disease; epub ahead of print
Dalgic B, Sari S, Dogan I, Unal S (2005) Chronic intestinal pseudoobstruction: report of four pediatric patients. Turk J Gastroenterol 16:93–7
Dy SM, Apostol CC (2010) Evidence-based approaches to other symptoms in advanced cancer. Cancer J 16:507
Mercadante S, Ferrera P, Villari P, Marrazzo A (2004) Aggressive pharmacological treatment for reversing malignant bowel obstruction. J Pain Symptom Manage 28:412–6
Soriano A, Davis MP (2011) Malignant bowel obstruction: Individualized treatment near the end of life. Cleve Clin J Med 78:197–206
Watanabe H, Inoue Y, Uchida K, Okugawa Y, Hiro J, Ojima E et al. (2007) Octreotide improved the quality of life in a child with malignant bowel obstruction caused by peritoneal dissemination of colon cancer. J Pediatr Surg 42:259–60
Abschnitt 6.1.3
Fleming ND, Varez-Secord A, von Gruenigen V, Miller MJ, Abernethy AP (2009) Indwelling catheters for the management of refractory malignant ascites: a systematic literature overview and retrospective chart review. J Pain Symptom Manage 38:341–9
Gerbes AL, Sauerbruch T, Dathe K (2011) S3-Leitlinie »Aszites, spontan bakterielle Peritonitis, hepatorenales Syndrom«. Z Gastroenterol 49:780–7
Sabri M, Saps M, Peters JM (2003) Pathophysiology and management of pediatric ascites. Curr Gastroenterol Rep 5:240–6
Yachha SK, Khanna V (2006) Ascites in childhood liver disease. Indian J Pediatr 73:819–24
Abschnitt 6.1.4
Gesellschaft für Pädiatrische Gastroenterologie und Ernahrung (GPGE) (2012) Leitlinie: Akute infektiöse Gastroenteritis.http://www.awmf.org/leitlinien/detail/ll/068-003.html. Abgerufen 17.03.2012
Al-Hussaini A, Butzner D (2012) Therapeutic applications of octreotide in pediatric patients. Saudi J Gastroenterol: Official Journal of the Saudi Gastroenterology Association 18:87
Azkur D, Yoldas T, Toyran M, Kocabas CN (2011) A pediatric case of anaphylaxis due to octreotide. Asian Pac J Allergy Immunol 29:361–3
Beckman RA, Siden R, Yanik GA, Levine JE (2000) Continuous octreotide infusion for the treatment of secretory diarrhea caused by acute intestinal graft-versus-host disease in a child. J Pediatr Hematol Oncol 22:344–50
Bernaola Aponte G, Bada Mancilla CA, Carreazo Pariasca NY, Rojas Galarza RA (2010) Probiotics for treating persistent diarrhoea in children. Cochrane Database Syst Rev 11:CD007401
Brunton LL (1996) Agents affecting gastrointestinal water flux and motility; emesis and antiemetics; bile acids and pancreatic enzymes. In: Goodman LS, Limbird LE, Milinoff PB (Hrsg) Goodman and Gilman’s the pharmacological basis of therapeutics, 9th ed. McGraw-Hill, New York; pp 917–37
Bujanover Y, Sullivan P, Liebman WM, Goodman J, Thaler MM (1979) Cholestyramine treatment of chronic diarrhea associated with immune deficiency syndrome. Clin Pediatr (Phila) 18:630–3
Cherny NI (2008) Evaluation and management of treatmentrelated diarrhea in patients with advanced cancer: a review. J Pain Symptom Manage 36:413–23
Coello-Ramirez P (1977) Cholestyramine in a case of a prolonged diarrhea after a partial ileocolectomy. Boletin medico del Hospital Infantil de México 34:325–8
Fontana M, Zuin G, Massironi E, Bastoni K, Altamura N, Principi N (1997) Antibiotic and cholestyramine treatment of chronic diarrhea in HIV-infected children. Ital J Gastroenterol Hepatol 29:22–4
Gryboski JD, Kocoshis S (1990) Effect of bismuth subsalicylate on chronic diarrhea in childhood: a preliminary report. Rev Infect Dis 12:S36-S40
Guandalini S (2011) Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol 45:S149-S153
Guarino A, Canani RB, Spagnuolo MI, Bisceglia M, Boccia MC, Rubino A (1998) In vivo and in vitro efficacy of octreotide for treatment of enteric cryptosporidiosis. Dig Dis Sci 43:436–41
Heikenen JB, Pohl JF, Werlin SL, Bucuvalas JC (2002) Octreotide in pediatric patients. J Pediatr Gastroenterol Nutr 35:600
Isolauri E, Vähäsarja V, Vesikari T (1986) Effect of cholestyramine on acute diarrhoea in children receiving rapid oral rehydration and full feedings. Ann Clin Res 18:99–102
Isolauri E, Vesikari T (1985) Oral rehydration, rapid feeding, and cholestyramine for treatment of acute diarrhea. J Pediatr Gastroenterol Nutr 4:366–74
Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH (2011) Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 11
Kekomaki M, Vilkki P, Gordin A, Salo H (1981) Loperamide as a symptomatic treatment in pediatric surgery: a doubleblind cross-over study. Z Kinderchir 32:237–43
Kreutzer EW, Milligan FD (1978) Treatment of antibiotic-associated pseudomembranous colitis with cholestyramine resin. Johns Hopkins Med J 143:67–72
Lamireau T, Galperine RI, Ohlbaum P, Demarquez JL, Vergnes P, Kurzenne Y et al. (1990) Use of a Long Acting Somatostatin Analogue in Controlling lleostomy Diarrhoea in Infants. Acta Paediatr 79:871–2
Lehert P, Chéron G, Calatayud GA, Cézard JP, Castrellón PG, Garcia JMM et al. (2011) Racecadotril for childhood gastroenteritis: an individual patient data meta-analysis. Dig Liver Dis 43:707–13
Li STT, Grossman DC, Cummings P (2007) Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis. PLoS medicine 4:e98
Liacouras CA, Piccoli DA (1996) Whole-Bowel Irrigation As an Adjunct to the Treatment of Chronic, Relapsing Clostridium Difficile Coitis. J Clin Gastroenterol 22:186–189
Litovitz T, Clancy C, Korberly B, Temple AR, Mann KV (1997) Surveillance of loperamide ingestions: an analysis of 216 poison center reports. Clin Toxicol 35:11–9
Nanba Y, Oka A, Ohno K (2007) Severe diarrhea associated with X-linked lissencephaly with absent corpus callosum and abnormal genitalia: a case report of successful treatment with the somatostatin analogue octreotide. Brain Develop 39:379–82
National Cancer Institute (2012) Gastrointestinal Complications: Diarrhoea. http://www.cancer gov/cancertopics/pdq/supportivecare/gastrointestinalcomplications/HealthProfessional/page5. Abgerufen 14.02.2012
Pai V, Porter K, Ranalli M (2011) Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease. Pediatric Blood & Cancer 56:45–9
Rees H, Markley MA, Kiely EM, Pierro A, Pritchard J (1998) Diarrhea after resection of advanced abdominal neuroblastoma: a common management problem. Surgery 123:568–72
Smith SS, Shulman DI, O’Dorisio TM, McClenathan DT, Borger JA, Bercu BB et al. (1987) Watery diarrhea, hypokalemia, achlorhydria syndrome in an infant: effect of the longacting somatostatin analogue SMS 201-995 on the disease and linear growth. J Pediatr Gastroenterol Nutr 6:710–6
Vesikari T, Isolauri E (1985) A comparative trial of cholestyramine and loperamide for acute diarrhoea in infants treated as outpatients. Acta Paediatr 74:650–4
Wright J, Gundry SW, Conroy RM (2007) A review of changing episode definitions and their effects on estimates of diarrhoeal morbidity. J Health Popul Nutr 25:448–55
Abschnitt 6.1.5
Ang SK, Shoemaker LK, Davis MP (2010) Nausea and Vomiting in Advanced Cancer. Am J Hosp Palliat Med 27:219–25
Antonarakis ES, Evans JL, Heard GF, Noonan LM, Pizer BL, Hain RDW (2004) Prophylaxis of acute chemotherapy-induced nausea and vomiting in children with cancer: What is the evidence? Pediatr Blood Cancer 43:651–8
Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR et al. (2011) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29:4189–98
Bateman DN, Rawlins MD, Simpson JM (1985) Extrapyramidal reactions with metoclopramide. Br Med J (Clin Res Ed) 291:930–2
Beckman RA, Siden R, Yanik GA, Levine JE (2000) Continuous octreotide infusion for the treatment of secretory diarrhea caused by acute intestinal graft-versus-host disease in a child. J Pediatr Hematol Oncol 22:344–50
Beretta S, Polastri D, Clerici CA, Casanova M, Cefalo G, Ferrari A et al. (2010) End of life in children with cancer: Experience at the Pediatric Oncology Departement of the Istituto Nazionale in Milan. Pediatr Blood Cancer 54: 88–91
Buchanan D, Muirhead K (2007) Letter to the editor: Use Intractable nausea and vomiting successfully related with granisetron 5-hydroxtrytamine type 3 receptor antagonists in Palliative Medicine. Palliat Med 21:725–6
Cotanch P, Hockenberry M (1985) Self-hypnosis as antiemetic therapy in children receiving chemotherapy. Oncol Nurs Forum 12:41–6
Currow DC, Coughlan M, Fardell B, Cooney NJ (1997) Use of ondansetron in palliative medicine. J Pain Symptom Manage 13:302–7
Del Giglio A, Soares HP, Caparroz C, Castro PC (2000) Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting. Cancer 89:2301–8
Dorman S, Perkins P (2010) Droperidol for treatment of nausea and vomiting in palliative care patients. Cochrane Database Syst Rev 10:CD006938
Dupuis LL, Nathan PC (2010) Optimizing emetic control in children receiving antineoplastic therapy: beyond the guidelines. Pediatric Drugs 12:51–61
Elfvin A, Göthberg G, Lönroth H, Saalman R, Abrahamsson H (2011) Temporary percutaneous and permanent gastric electrical stimulation in children younger than 3 years with chronic vomiting. J Pediatr Surg 46:655–61
Fedorowicz Z, Jagannath VA, Carter B (2011) Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. status and date: Cochrane Database Syst Rev 7(9):CD005506
Gore L, Chawla S, Petrilli A, Hemenway M, Schissel D, Chua V et al. (2009) Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: A randomized, double-blind, placebo-controlled study of efficacy and tolerability. Pediatr Blood Cancer 52:242–7
Guarino A, Canani RB, Spagnuolo MI, Bisceglia M, Boccia MC, Rubino A (1998) In vivo and in vitro efficacy of octreotide for treatment of enteric cryptosporidiosis. Dig Dis Sci 43:436–41
Hardy J, Daly S, McQuade B, Albertsson M, Chimontsi-Kypriou V, Stathopoulos G et al. (2002) A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg po with placebo and metoclopramide 10 mg tds po in the treatment of opioid-induced nausea and emesis in cancer patients. Support Care Cancer 10:231–6
Hardy JR, O’Shea A, White C, Gilshenan K, Welch L, Douglas C (2010) The efficacy of haloperidol in the management of nausea and vomiting in patients with cancer. J Pain Symptom Manage 40:111–6
Hesketh PJ (2008) Chemotherapy-induced nausea and vomiting. N Engl J Med 358:2482–94
Hesketh PJ, Grunberg SM, Gralla RJ, Warr DG, Roila F, de Wit R et al. (2003) The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin. The Aprepitant Protocol 052 Study Group. J Clin Oncol 21:4112–9
Hongo T, Watanabe C, Okada S, Inoue N, Yajima S, Fujii Y et al. (2003) Analysis of the circumstances at the end of life in children with cancer: symptoms, suffering and acceptance. Pediatr Int 45:60–4
Hooke MC, Grund E, Quammen H, Miller B, McCormick P, Bostrom B (2007) Propofol use in pediatric patients with severe cancer pain at the end of life. J Pediatr Oncol Nurs 24:29–34
Jacknow DS, Tschann JM, Link MP, Boyce WT (1994) Hypnosis in the prevention of chemotherapy-related nausea and vomiting in children: A prospective study. J Dev Behav Pediatr 15:258–64
Jackson WC, Tavernier L (2003) Olanzapine for intractable nausea in palliative care patients. J Pall Med 6:251–5
Jordan K, Hinke A, Grothey A, Schmoll HJ (2005) Granisetron versus tropisetron for prophylaxis of acute chemotherapy-induced emesis: A pooled analysis. Support Care Cancer 13:26–31
Khoo D, Motson R, Denman K, Hall E, Riley J, Waxman J (1994) Palliation of malignant intestinal obstruction using octreotide. Eur J Cancer 30:28–30
Koga T, Fukuda H (1992) Neurons in the nucleus of the solitary tract mediating inputs from emetic vagal afferents and the area postrema to the pattern generator for the emetic act in dogs. Neurosci Res 14:166–79
Lamireau T, Galperine RI, Ohlbaum P, Demarquez JL, Vergnes P, Kurzenne Y et al. (1990) Use of a Long Acting Somatostatin Analogue in Controlling lleostomy Diarrhoea in Infants. Acta Paediatr 79:871–2
LeBaron S, Zeltzer L (1984) Behavioral intervention for reducing chemotherapy-related nausea and vomiting in adolescents with cancer. J Adolesc Health Care 5:178–82
Lee A, Fan LT (2009) Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev 2
Lundström S, Zachrisson U, Fürst CJ (2005) When nothing helps: propofol as sedative and antiemetic in palliative cancer care. J Pain Symptom Manage 30:570–7
Maida V, Ennis M, Irani S, Corbo M, Dolzhykov M (2008) Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring. J Support Oncol 6:119
Mangili G, Franchi M, Mariani A, Zanaboni F, Rabaiotti E, Frigerio L et al. (1996) Octreotide in the management of bowel obstruction in terminal ovarian cancer. Gynecol Oncol 61:345–8
Mannix K (2006) Palliation of nausea and vomiting in malignancy. Clin Med 6:144–7
Mannix K (2009) Palliation of nausea and vomiting. Br J of Hosp Med 70:192
Mercadante S, Spoldi E, Caraceni A, Maddaloni S, Simonetti MT (1993) Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 7:295–9
Mystakidou K, Befon S, Liossi C, Vlachos L (1998) Comparison of tropisetron and chlorpromazine combinations in the control of nausea and vomiting in patients with advanced cancer. J Pain Symptom Manage 15:176–84
Passik SD, Lundberg J, Kirsh KL, Theobald D, Donaghy K, Holtsclaw E et al. (2002) A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain. J Pain Symptom Manage 23:526–32
Porreca F, Ossipov MH (2009) Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options. Pain Med 10:654–62
Riad W, Altaf R, Abdulla A, Oudan H (2007) Effect of midazolam, dexamethasone and their combination on the prevention of nausea and vomiting following strabismus repair in children. Eur J Anaesthesiol 24:697–701
Richardson J, Smith JE, McCall G, Richardson A, Pilkington K, Kirsch I (2007) Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence. Eur J Cancer Care 16:402–12
Riley J, Fallon MT (1994) Octreotide in terminal malignant obstruction of the gastrointestinal tract. Eur J Palliat Care 1:23–5
Ripaldi M, Parasole R, De Simone G, D’Amico MR, Migliorati R, Zanotta G et al. (2010) Palonosetron to prevent nausea and vomiting in children undergoing BMT. Efficacy and safety. Bone Marrow Transplant 45:1663–4
Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E et al. (2010) Guideline update for MASCC and ESMO in the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 21:v232-v243
Roscoe JA, Morrow GR, Aapro MS, Molassiotis A, Olver I (2011) Anticipatory nausea and vomiting. Support Care Cancer 19:1533–8
Schroeter E, Schmitz A, Haas T, Weiss M, Gerber AC (2012 Jan 1) »Low-dose«-Droperidol-Gabe bei Kindern. Anaesthesist 61:30–4
Smith AR, Repka TL, Weigel BJ (2005) Aprepitant for the control of chemotherapy induced nausea and vomiting in adolescents. Pediatr Blood Cancer 45:857–60
Smith SS, Shulman DI, O‘Dorisio TM, McClenathan DT, Borger JA, Bercu BB et al. (1987) Watery diarrhea, hypokalemia, achlorhydria syndrome in an infant: effect of the longacting somatostatin analogue SMS 201-995 on the disease and linear growth. J Pediatr Gastroenterol Nutr 6:710–6
Stockhorst U, Wiener JA, Klosterhalfen S, Klosterhalfen W, Aul C, Steingrueber HJ (1998) Effects of overshadowing on conditioned nausea in cancer patients: an experimental study. Physiolog Behav 64:743–53
Tramér MR, Carroll D, Campbell FA, Reynolds DJM, Moore RA, McQuay HJ (2001) Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 323:16–21
Twycross R, Back I (1998) Nausea and vomiting in advanced cancer. Eur J Pall Care 5:39–45
Ventafridda V, Oliveri E, Caraceni A, Spoldi E, de Conno F, Saita L et al. (1987) A retrospective study on the use of oral morphine in cancer pain. J Pain Symptom Manage 2:77–81
Wang SM, Kain ZN (2002) P6 acupoint injections are as effective as droperidol in controlling early postoperative nausea and vomiting in children. Anesthesiology 97:359–66
Williamson EM, Evans FJ (2000) Cannabinoids in clinical practice. Drugs 60:1303–14
Wilson J, Plourde JY, Marshall D, Yoshida S, Chow W, Harsanyi Z et al. (2002) Long-term safety and clinical effectiveness of controlled-release metoclopramide in cancer-associated dyspepsia syndrome: a multicentre evaluation. J Palliat Care 18:84–91
Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S et al. (2000) Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342:326–33
Zhang TG, Stronge WJ, Porcel JM, Salud A, Porta J, Schoenenberger JA (1998) Antiemetic efficacy of subcutaneous 5-HT3 receptor antagonists in terminal cancer patients. J Pain Symptom Manage 15:265–6
Abschnitt 6.1.6.1
Aggarwal SK, Carter GT, Sullivan MD, ZumBrunnen C, Morrill R, Mayer JD (2009) Medicinal lise of cannabis in the United States: Historical perspectives, current trends, and future directions. J Opioid Manage 5(3):153–68
Azcona C, Castro L, Crespo E, Jimenez M, Sierrasesumaga L (1996) Megestrol acetate therapy for anorexia and weight loss in children with malignant solid tumours. Aliment Pharmacol Therap 10:577–86
Brady MT, Koranyi KI, Hunkler JA (1994) Megestrol acetate for treatment of anorexia associated with human immunodeficiency virus infection in children. Pediatr Infect Dis J 13:754–6
Clarick RH, Hanekom WA, Yogev R, Chadwick EG (1997) Megestrol acetate treatment of growth failure in children infected with human immunodeficiency virus. Pediatr 99:354–7
Eubanks V, Koppersmith N, Wooldridge N, Clancy JP, Lyrene R, Arani RB et al. (2002) Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis. J Pediatr 140:439–44
Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D et al. (2008) Cachexia: a new definition. Clin Nutr 27:793–9
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL et al. (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489–95
Gullett NP, Hebbar G, Ziegler TR (2010) Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting. Am J Clin Nutr 91:1143S-7S
Hobbs DJ, Bunchman TE, Weismantel DP, Cole MR, Ferguson KB, Gast TR et al. (2010) Megestrol acetate improves weight gain in pediatric patients with chronic kidney disease. J Ren Nutr 20:408–13
Isaac JH (1999) Megestrol acetate treatment of failure to thrive in congenital heart disease. Pediatr Cardiol 20:350
Lai JS, Cella D, Peterman A, Barocas J, Goldman S (2005) Anorexia/cachexia-related quality of life for children with cancer. Cancer 104:1531–9
Lorenz R (2004) On the application of cannabis in paediatrics and epileptology. Neuroendocrinology Letters 25:40–4
Mak RH, Cheung WW, Zhan JY, Shen Q, Foster BJ (2012) Cachexia and protein-energy wasting in children with chronic kidney disease. Pediatr Nephrol 27:173–81
Marchand V, Baker SS, Stark TJ, Baker RD (2000) Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis. J Pediatr Gastroenterol Nutr 31:264–9
Meacham LR, Mazewski C, Krawiecki N (2003) Mechanism of transient adrenal insufficiency with megestrol acetate treatment of cachexia in children with cancer. J Pediatr Hematol Oncol 25:414
Nasr SZ, Hurwitz ME, Brown RW, Elghoroury M, Rosen DA (1999) Treatment of anorexia and weight loss with megestrol acetate in patients with cystic fibrosis. Pediatr Pulmonol 28:380–2
Orme LM, Bond JD, Humphrey MS, Zacharin MR, Downie PA, Jamsen KM et al. (2003) Megestrol Acetate in pediatric oncology patients may lead to severe, symptomatic adrenal suppression. Cancer 98:397–405
Pascual Lopez A, Figuls M, Urrutia Cuchi G, Graciela Berenstein E, menar Pasies B, Balcells Alegre M et al. (2004) Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome. J Pain Symptom Manage 27:360–9
Potter J, Hami F, Bryan T, Quigley C (2003) Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliat Med 17:310–4
Schmid I, Stachel DK, Freudenberg S, Schmitt M, Schuster F, Haas RJ (2002) Megestrol acetate to correct the nutritional status in an adolescent with growth hormone deficiency: Increase of appetite and body weight but only by increase of body water and fat mass followed by profound cortisol and testosterone depletion. Klin Paediatr 214:54–7
Stockheim JA, Daaboul JJ, Yogev R, Scully SP, Binns HJ, Chadwick EG (1999) Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate. J Pediatr 134:368–70
Abschnitt 6.1.6.2
Frisancho AR (1981) New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 34:2540–5
Gisel EG, Patrick J (1988) Identification of children with cerebral palsy unable to maintain a normal nutritional state. The Lancet 331:283–6
Krick J, Murphy PE, Markham JFB, Shapiro BK (1992) A proposed formula for calculating energy needs of children with cerebral palsy. Develop Med Child Neurol 34:481–7
Marchand V, Motil KJ (2006) Nutrition support for neurologically impaired children: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 43:123–35
Motil KJ (1994) Enteral nutrition in the neurologically impaired child. In: Baker SB, Baker RD, Davis A (Hrsg) Pediatric Enteral Nutrition. Chapman and Hall, New York; pp 217–37
Spender QW, Cronk CE, Charney EB, Stallings VA (1989) Assessment of linear growth of children with cerebral palsy: use of alternative measures to height or length. Develop Med Child Neurol 31:206–14
Abschnitt 6.1.7
Allen G, Logan R, Gue S (2010) Oral Manifestations of Cancer Treatment in Children. Clin J Oncol Nurs 14:481–90
Balmer C, Wells AV (1997) Basic principle of cancer treatment and cancer chemotherapy. In: Dipiro J, Talbert R, Yee G (Hrsg) Pharmacotherapy, 3th ed. Appleton and Lange, Stamfort, CT
Bensadoun RJ, Nair RG (2012) Low-level laser therapy in the prevention and treatment of cancer therapy-induced mucositis: 2012 state of the art based on literature review and meta-analysis. Curr Opin Oncol 24: epub ahead of print
Bjordal JM, Bensadoun RJ, Tunér J, Frigo L, Gjerde K, Lopes-Martins RAB (2011) A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Support Care Cancer: 19(8):1069–77
Clarkson JE, Worthington HV, Furness S, McCabe M, Khalid T, Meyer S (2010) Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 8:CD001973
Cruz LB, Ribeiro AS, Rech A, Rosa LGN, Castro Jr CG, Brunetto AL (2007) Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy. Pediatr Blood Cancer 48:435–40
Drake R, Frost J, Collins JJ (2003) The symptoms of dying children. J Pain Symptom Manage 26:594–603
Eilers J, Million R (2011) Clinical Update: Prevention and Management of Oral Mucositis in Patients with Cancer; Sem Oncol Nurs 27(4) e1-e16
Gandemer V, Deley MCL, Dollfus C, Auvrignon A, Bonnaure-Mallet M, Duval M et al. (2007) Multicenter randomized trial of chewing gum for preventing oral mucositis in children receiving chemotherapy. J Pediatr Hematol Oncol 29:86–94
Knoben JE, Anderson PO (1997) Handbook of clinical drug data, Appleton and Lange, Stamford, CT
Kuhn A, Porto FA, Miraglia P, Brunetto AL (2009) Low-level infrared laser therapy in chemotherapy-induced oral mucositis: a randomized placebo-controlled trial in children. J Pediatr Hematol Oncol 31:33
Shenep JL, Kalwinsky DK, Hutson PR, George SL, Dodge RK, Blankenship KR et al. (1988) Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapyinduced mucositis. J Pediatr 113:758–63
Smith RG, Burtner AP (1994) Oral side-effects of the most frequently prescribed drugs. Spec Care Dentist 14:96–102
Sweeney MP, Bagg J (1995) Oral care for hospice patients with advanced cancer. Dent Update 22:424–7
Worthington HV, Clarkson JE, Eden OB (2011) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev:CD000978
http://www.Mukositis.de. Abgerufen 17.03.2012
Abschnitt 6.1.9
Dand P, Sakel M (2010) The management of drooling in motor neurone disease. Int J Palliat Nurs 16:560–4
De Simone GG, Eisenchlas JH, Junin M, Pereyra F, Brizuela R (2006) Atropine drops for drooling: a randomized controlled trial. Palliat Med 20:665–71
Hockstein NG, Samadi DS, Gendron K, Handler SD (2004) Sialorrhea: a management challenge. Am Fam Physician 69:2628–34
Horimoto Y, Tomie H, Hanzawa K, Nishida Y (1991) Scopolamine patch reduces postoperative emesis in paediatric patients following strabismus surgery. Can J Anaesth 38:441–4
Hyson HC, Johnson AM, Jog MS (2002) Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study. Mov Disord 17:1318–20
Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M (2000) Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study. Arch Pediatr Adolesc Med 154:1214–8
Rapoport A (2010) Sublingual Atropine Drops for the Treatment of Pediatric Sialorrhea. J Pain Symptom Manage 40:783–8
Reddihough D, Erasmus CE, Johnson H, McKellar GMW, Jongerius PH (2010) Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: international consensus statement. Eur J Neurol 17:109–21
Reed J, Mans CK, Brietzke SE (2009) Surgical management of drooling: a meta-analysis. Archives of Otolaryngology – Head Neck Surg 135:924–31
Reid SM, Johnson HM, Reddihough DS (2010) The Drooling Impact Scale: a measure of the impact of drooling in children with developmental disabilities. Develop Med Child Neurol 52:e23-e28
Sullivan PB, Lambert B, Rose M, Ford-Adams M, Johnson A, Griffiths P (2000) Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding Study. Develop Med Child Neurol 42:674–80
Thomas-Stonell N, Greenberg J (1988) Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 3:73–8
Abschnitt 6.1.10
[1] Chang FY, Lu CL (2012) Hiccup: Mystery, Nature and Treatment. J Neurogastroenterol Motil 18:123–30
Cymet TC (2002) Retrospective analysis of hiccups in patients at a community hospital from 1995-2000. J Natl Med Assoc 94:480–3
Federspil PA, Zenk J (1999) Singultus. HNO 47:867–75
Fesmire FM (1988) Termination of intractable hiccups with digital rectal massage. Ann Emerg Med 17:872
Guelaud C, Similowski T, Bizec JL, Cabane J, Whitelaw WA, Derenne JP (1995) Baclofen therapy for chronic hiccup. Eur Respir J 8:235–7
Hiyama T, Yoshihara M, Tanaka S, Haruma K, Chayama K (2009) Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract. J Gastroenterol Hepatol 24:537–46
Landers C, Turner D, Makin C, Zaglul H, Brown R (2008) Propofol associated hiccups and treatment with lidocaine. Anesth Analg 107:1757–8
Lewis JH (1985) Hiccups: causes and cures. J Clin Gastroenterol 7:539
Marhofer P, Glaser C, Krenn CG, Grabner CM, Semsroth M (1999) Incidence and therapy of midazolam induced hiccups in paediatric anaesthesia. Pediatr Anesth 9:295–8
Petroianu G, Hein G, Petroianu A, Bergler W, Rufer R (1997) Idiopathic chronic hiccup: combination therapy with cisapride, omeprazole, and baclofen. Clin Ther 19:1031–8
Porzio G, Aielli F, Verna L, Aloisi P, Galletti B, Ficorella C (2010) Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience. Clin Neuropharmacol 33:179
Potter J, Hami F, Bryan T, Quigley C (2003) Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliat Med 17:310–4
Samuels L (1952) Hiccup: A ten year review of anatomy, etiology, and treatment. Can Med Assoc J 67:315–22
Seker MM, Aksoy S, Özdemir NY, Uncu D, Civelek B, Akinci MB et al. (2012) Successful treatment of chronic hiccup with baclofen in cancer patients. Med Oncol 29:1369–70
Smith HS, Busracamwongs A (2003) Management of hiccups in the palliative care population. Am J Hosp Palliat Med 20:149–54
Souadjian JV, Cain JC (1968) Intractable hiccup. Etiologic factors in 220 cases. Postgrad Med 43:72
Stueber D, Swartz CM (2006) Carvedilol suppresses intractable hiccups. J Am Board Fam Med 19:418–21
Tay SS, Yadav RR (2010) Novel use of baclofen in cancer patients for the treatment of hiccups. Ann Acad Med Singapore 39:154
Tegeler ML, Baumrucker SJ (2008) Gabapentin for intractable hiccups in palliative care. Am J Hosp Palliat Care 25:52–4
Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: Relationshipn to age, gender, and performance status in 1,000 patients. Supp Care Cancer 8:175–9
Zu Abschnitt 6.2: Abschnitt 6.2.1 bis 6.2.7
Aksu F (2011a) NeuroPädiatrie, UNI-MED, Bremen
Aksu F (2011b) Zerebrale Anfälle. In: Aksu F (Hrsg) NeuroPädiatrie. UNI-MED, Bremen; pp 505–66
Aoki R (1998) The Development of BOTOX [R]-Its History and Pharmacology. Pain Digest 8:337–41
Ashwal S, Bale Jr JF, Coulter DL, Eiben R, Garg BP, Hill A et al. (1992) The persistent vegetative state in children: report of the Child Neurology Society Ethics Committee. Ann Neurol 32:570–6
Bach JR, Campagnolo DI, Hoeman S (1991) Life satisfaction of individuals with Duchenne muscular dystrophy using long-term mechanical ventilatory support. Am J Phys Med Rehabil/Ass Acad Physiatr 70:129
Barwood S, Baillieu C, Boyd R, Brereton K, Low J, Nattrass G et al. (2000) Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Develop Med Child Neurol 42:116–21
Baumann JU (1986) Behandlung kindlicher spastischer Fußdeformitäten. Orthopäde 15:191–8
Bower E, Michell D, Burnett M, Campbell MJ, McLellan DL (2001) Randomized controlled trial of physiotherapy in 56 children with cerebral palsy followed for 18 months. Develop Med Child Neurol 43:4–15
Caviness JN, Brown P (2004) Myoclonus: current concepts and recent advances. Lancet Neurol 3:598–607
Celesia GG (1997) Persistent vegetative state: clinical and ethical issues. Theor Med Bioeth 18:221–36
Chicoine MR, Park TS, Kaufman BA (1997) Selective dorsal rhizotomy and rates of orthopedic surgery in children with spastic cerebral palsy. J Neurosurg 86:34–9
Coffey RJ, Cahill D, Steers W, Park TS, Ordia J, Meythaler J et al. (1993) Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 78:226–32
Collin C, Davies P, Mutiboko IK, Ratcliffe S (2007) Randomized controlled trial of cannabisGÇÉbased medicine in spasticity caused by multiple sclerosis. Eur J Neurol 14:290–6
Coward DM (1994) Tizanidine: neuropharmacology and mechanism of action. Neurology 44:S6-S10, discussion 10–1
Crest C, Dupont S, Leguern E, Adam C, Baulac M (2004) Levetiracetam in progressive myoclonic epilepsy. Neurology 62:640–3
Cutter NC, Scott DD, Johnson JC, Whiteneck G (2000) Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial. Arch Phys Med Rehabil 81:164–9
Dressnandt J, Tölle TR, Konstanzer A, Conrad B, Weinzierl FX (1996) Acute overdose of intrathecal baclofen. J Neurol 243:482–3
Eldridge R, Iivanainen M, Stern R, Koerber T, Wilder BJ (1983) »Baltic« myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet 2:838
Fahn S, Marsden CD, van Woert MH (1986) Definition and classification of myoclonus. In: Fahn S, Marsden CD, Woert MH (Hrsg) Advances in Neurology, 43th ed. Raven Press, New York; pp 1–5
Fedi M, Reutens D, Dubeau F, Andermann E, D’Agostino D, Andermann F (2001) Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy. Arch Neurol 58:781–6
Genton P, Gelisse P (2000) Antimyoclonic effect of levetiracetam. Epileptic disorders: international epilepsy journal with videotape 2:209–12
Genton P, Guerrini R, Remy C (1999) Piracetam in the treatment of cortical myoclonus. Pharmacopsychiatr 32:49–53
Hafkemeier U (2003) Schmerzreduzierende, funktionsverbessernde Operationen bei Kindern mit Mehrfachbehinderung. NeuroPädiatrie Klin Prax 2:25–7
Humm AM, Pabst C, Lauterburg T, Burgunder JM (2000) Enkephalin and aFGF are differentially regulated in rat spinal motoneurons after chemodenervation with botulinum toxin. Exp Neurol 161:361–72
Kluger G, Lütjen S, Granel M (2003) Die intrathekale Baclofentherapie (ITB) bei Kindern mit schwerer Spastik und / oder Dystonie: 15 Jahre Erfahrung bei 68 Patienten. Neuropädiatr Klin Prax 2:18–24
Krämer G, Bergmann A, Despland PA, Konig S, Kurlemann G, Kurth C et al. (2005) Derzeitiger Stellenwert intravenöser Valproinsäure in der Therapie des generalisierten tonischklonischen Status epilepticus. Akt Neurol 32:263–74
Kyllerman M, Ben-Menachem E (1998) Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients. Epilepsy Res 29:109–14
Lahat E, Goldman M, Barr J, Bistritzer T, Berkovitch M (2000) Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. BMJ 321:83–6
Lahat E, Goldman M, Barr J, Eshel G, Berkovitch M (1998) Intranasal midazolam for childhood seizures. Lancet 352:620
Latash ML, Penn RD, Corcos DM, Gottlieb GL (1989) Short-term effects of intrathecal baclofen in spasticity. Exp Neurol 103:165–72
Lim HW (2005) Pathogenesis of photosensitivity in the cutaneous porphyrias. J Invest Dermatol 124:xvi-xvii
Lim LL, Ahmed A (2005) Limited efficacy of levetiracetam on myoclonus of different etiologies. Parkinsonism Rel Dis 11:135–7
Limbrock GJ, Castillo-Morales R, Hoyer H, Stover B, Onufer CN (1993) The Castillo-Morales approach to orofacial pathology in Down syndrome. Int J Orofacial Myology 19:30–7
Magaudda A, Gelisse P, Genton P (2004) Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations. Epilepsia 45:678–81
Meinck HM, Schönle PW, Conrad B (1989) Effect of cannabinoids on spasticity and ataxia in multiple sclerosis. J Neurol 236:120–2
Müller H, Zierski J, Dralle D, Börner U, Hoffmann O (1987) The effect of intrathecal baclofen on electrical muscle activity in spasticity. J Neurol 234:348–52
Obeso JA, Artieda J, Quinn N, Rothwell JC, Luquin MR, Vaamonde J et al. (1988) Piracetam in the treatment of different types of myoclonus. Clin Neuropharmacol 11:529–36
Peacock WJ, Staudt LA (1991) Selective posterior rhizotomy: further comments. J Child Neurol 6:173–80
Pellock JM (2004) Myoclonic epilepsies: syndromes and their treatment. Suppl Clin Neurophysiol 57:425–32
Penn RD, Kroin JS (1985) Continuous intrathecal baclofen for severe spasticity. Lancet 326:125–7
Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B et al. (1989) Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320:1517–21
Polo KB, Jabbari B (1994) Effectiveness of botulinum toxin type A against painful limb myoclonus of spinal cord origin. Mov Disord 9:233–5
Putty TK, Shapiro SA (1991) Efficacy of dorsal longitudinal myelotomy in treating spinal spasticity: a review of 20 cases. J Neurosurg 75:397–401
Rodillo EB, Fernandez-Bermejo E, Heckmatt JZ, Dubowitz V (1988) Prevention of rapidly progressive scoliosis in Duchenne muscular dystrophy by prolongation of walking with orthoses. J Child Neurol 3:269–74
Rosales RL, Arimura K, Takenaga S, Osame M (1996) Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve 19:488–96
Russo EB (2003) Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Neurology 60:729–30
Schmidt D, Elger CE (1999) Symptomatishe und kryptogene Epilepsien. In: Schmidt D, Elger CE (Hrsg) Praktische Epilepsiebehandlung. Thieme, Stuttgart
Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB (1996) Botulinum-A Toxin as a Treatment of Detruosor-Sphincter Dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 155:1023–9
Simonds AK, Ward S, Heather S, Bush A, Muntori F (2000) Outcome of paediatric domicilliary mask ventilation in neuromuscular and skeletal disease. Eur Resp Jl 16: 476–81
Stewart-Wynne EG, Silbert PL, Buffery S, Perlman D, Tan E (1991) Intrathecal baclofen for severe spasticity: five years experience. Clin Exp Neurol 28:244–55
Striano P, Manganelli F, Boccella P, Perretti A, Striano S (2005) Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study. Mov Disord 20:1610–4
Uthman BM, Reichl A (2002) Progressive myoclonic epilepsies. Curr Treat Opt Neurol 4:3–17
Van Den Bergh P, De Beukelaer M, Deconinck N (1996) Effect of muscle denervation on the expression of substance P in the ventral raphe-spinal pathway of the rat. Brain Res 707:206–12
Wallace SJ (1998) Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide. Epilepsy Res 29:147–54
Waterhouse EJ (2002) Short-and long-term outcomes after status epilepticus. Epilepsy Curr 2:111
Weindling AM, Cunningham CC, Glenn SM, Edwards RT, Reeves DJ (2007) Additional therapy for young children with spastic cerebral palsy: a randomised controlled trial. In: Walley T (Hrsg). Gray Publishing, Tunbridge Wells, Kent, UK
Wissel J, Müller J, Dressnandt J, Heinen F, Naumann M, Topka H et al. (2000) Management of spasticity associated pain with botulinum toxin A. J Pain Symptom Manage 20:44–9
Yu KT, Mills S, Thompson N, Cunanan C (2003) Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia 44:724–6
Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A et al. (2003) Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 362:1517–26
Abschnitt 6.2.8
American Academy of Sleep Medicine (2005) International classification of sleep disorders, 2nd ed. Diagnostic and coding Manual
Anders TF, Keener MA (1989) Sleep-wake state development and disorders of sleep in infants, children, and adolescents. In: Levine MD, Carey WB, Crocker AC, Gross RT (eds) Developmental-Behavioural Pediatrics. Saunders, Philadelphia; pp 596–605
Brehaut JC, Kohen DE, Raina P, Walter SD, Russell DJ, Swinton M et al. (2004) The health of primary caregivers of children with cerebral palsy: how does it compare with that of other Canadian caregivers? Pediatr 114:e182
Bruni O, 0ttaviano S, Guidetti V, Romoli V, Innocenzi M, Cortesi F et al. (1996) The Sleep Disturbance Scale for Children (SDSC) – Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence. J Sleep Res 5:251–61
Burton A (1990) The management of sleep problems. Profound retardation and multiple impairment, Vol 3. Chapman and Hall, London; pp 275–84
Byars AW, Byars KC, Johnson CS, de Grauw TJ, Fastenau PS, Perkins S et al. (2008) The relationship between sleep problems and neuropsychological functioning in children with first recognized seizures. Epilep Behav 13:607–13
Chhangani B, Greydanus DE, Patel DR, Feucht C (2011) Pharmacology of Sleep Disorders in Children and Adolescents. Pediatr Clin North Am 58:273–91
Colville GA, Watters JP, Yule W, Ax M (1996) Sleep Problems in Children with Sanfilippo Sndrome. Developmental Med Child Neurol 38:538–44
Cortesi F, Giannotti F, Ottaviano S (1999) Sleep problems and daytime behavior in childhood idiopathic epilepsy. Epilepsia 40:1557–65
Culebras A (2005) Sleep disorders and neuromuscular disease. Semin Neurol 25:33–8
Deutsche Gesellschaft fuer Kinder- und Jugendpsychiatrie und Psychotherapie (2007) Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter. Deutscher Ärzte-Verlag, Köln
Didden R, Korzilius H, Aperlo B, Overloop C, Vries M (2002) Sleep problems and daytime problem behaviours in children with intellectual disability. J Intellect Disabil Res 46:537–47
Didden R, Sigafoos J (2001) A review of the nature and treatment of sleep disorders in individuals with developmental disabilities. Res Dev Disabil 22:255–72
Dodge NN, Wilson GA (2001) Melatonin for treatment of sleep disorders in children with developmental disabilities. J Child Neurol 16:581
Dorris L, Scott N, Zuberi S, Gibson N, Espie C (2008) Sleep problems in children with neurological disorders. Develop Neurorehabil 11:95–114
Dykens EM, Smith ACM (1998) Distinctiveness and correlates of maladaptive behaviour in children and adolescents with Smith-Magenis syndrome. J Intellect Disabil Res 42:481–9
Fauteck JD, Schmidt H, Lerchl A, Kurlemann G, Wittkowski W (1999) Melatonin in epilepsy: first results of replacement therapy and first clinical results. Biol Signals Recept 8:105–10
Fricke-Oerkermann L, Plück J, Schredl M, Heinz K, Mitschke A, Wiater A et al. (2007) Prevalence and Course of Sleep Problems in Childhood. Sleep 30:1371–7
Glaze DG (2004) Childhood insomnia: why Chris can’t sleep. Pediatr Clin North Am 51:33–50
Gordon N (2000) The therapeutics of melatonin: a paediatric perspective. Brain Dev 22:213–7
Gradisar M, Dohnt H, Gardner G, Paine S, Starkey K, Menne A et al. (2011) A randomized controlled trial of cognitivebehavior therapy plus bright light therapy for adolescent delayed sleep phase disorder. Sleep 34:1671–80
Grubar JC (1983) Sleep and mental deficiency. Rev Electroencephalogr Neurophysiol Clin 13:107–14
Handwerker G (2006) Epworth-Sleepiness-Scale für Kinder (ESS-K). Kompendium Schlafmedizin für Ausbildung, Klinik und Praxis, Deutsche Gesellschaft für Schlafforschung und Schlafmedizin. Ecomed Medizin, Landsberg
Hemmingsson H, Stenhammar AM, Paulsson K (2009) Sleep problems and the need for parental night-time attention in children with physical disabilities. Child Care Health Dev 35:89–95
Heussler M, Harri M, Cooper D, Dakin C, Suresh S, Williams G (2008) Hypersomnolence in Prader Willi Syndrome. J Intellect Disabil Res 52:814
Ivanenko A, Crabtree VML, Tauman R, Gozal D (2003) Melatonin in children and adolescents with insomnia: a retrospective study. Clin Pediatr (Phila) 42:51
Jan JE, Espezel H, Appleion RE (1994) The treatment of sleep disorders with melatonin. Develop Med Child Neurol 36:97–107
Jan JE, Freeman RD, Fast DK (1999) Melatonin treatment of sleep-wake cycle disorders in children and adolescents. Develop Med Child Neurol 41:491–500
Jan JE, Owens JA, Weiss MD, Johnson KP, Wasdell MB, Freeman RD et al. (2008 Dec 1) Sleep Hygiene for Children With Neurodevelopmental Disabilities. Pediatr 122:1343–50
Jan MMS (2000) Melatonin for the treatment of handicapped children with severe sleep disorders. Pediatr Neurol 23:229–32
Kuhn BR, Elliott AJ (2003) Treatment efficacy in behavioral pediatric sleep medicine. J Psychosom Res 54:587–97
Lindblom N, Heiskala H, Kaski M, Leinonen L, Nevanlinna A, Iivanainen M et al. (2001) Neurological impairments and sleep-wake behaviour among the mentally retarded. J Sleep Res 10:309–18
MacCrosain AM, Byrne MC (2009) Are we ignoring the problem of sleep disorder in children with intellectual disabilities? Ir J Med Sci 178:427–31
Matricciani LA, Olds TS, Blunden S, Rigney G, Williams MT (2012) Never enough sleep: a brief history of sleep recommendations for children. Pediatr 129:556
McArthur AJ, Budden SS (1998) Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment. Develop Med Child Neurol 40:186–92
Mellies U, Ragette R, Schwake C, Boehm H, Voit T, Teschler H (2003) Daytime predictors of sleep disordered breathing in children and adolescents with neuromuscular disorders. Neuromuscul Disord 13:123–8
Meltzer LJ, Mindell JA (2006) Impact of a child’s chronic illness on maternal sleep and daytime functioning. Arch Intern Med 166:1749–55
Mindell JA, Emslie G, Blumer J, Genel M, Glaze D, Ivanenko A et al. (2006) Pharmacologic management of insomnia in children and adolescents: consensus statement. Pediatr 117:e1223-e1232
Moldofsky H, Dickstein JB (1999) Sleep and cytokine-immune functions in medical, psychiatric and primary sleep disorders. Sleep Med Rev 3:325–37
Owens J (2008) Classification and epidemiology of childhood sleep disorders. Sleep Med Clin 2:353–61
Palm L (1997) Long term melatonin treatment in blind children and young adults with circadian sleep wake disturbances. Develop Med Child Neurol 39:319–25
Pesonen AK, Räikkönen K, Paavonen EJ, Heinonen K, Komsi N, Lathi J et al. (2010) Sleep duration and regularity are associated with behavioral problems in 8-year-old children. Int J Behav Med 17:298–305
Polimeni M, Richdale A, Francis A (2007) The impact of children‘ s sleep problems on the family and behavioural processes related to their development and maintenance. E-J Appl Psychol 3
Provini F, Lombardi C, Lugaresi E (2005) Insomnia in Neurological Diseases. Semin Neurol 25:81–9
Quine L (1991) Sleep problems in children with mental handicap. J Intellect Disabil Res 35:269–90
Raina P, O’Donnell M, Rosenbaum P, Brehaut J, Walter SD, Russell D et al. (2005) The Health and Well-Being of Caregivers of Children With Cerebral Palsy. Pediatr 115:e626-e636
Richdale AF, Cotton S, Gavidia-Payne S (2000) Stress, behaviour, and sleep problems in children with an intellectual disability. J Intellect Develop Disabil 25:147–61
Roberts K, Lawton D (2001) Acknowledging the extra care parents give their disabled children. Child Care Health Develop 27:307–20
Robinson AM, Richdale AL (2004) Sleep problems in children with an intellectual disability: parental perceptions of sleep problems, and views of treatment effectiveness. Child Care Health Develop 30:139
Robinson ME, Wise EA (2004) Prior pain experience: Influences on the observation of experimental pain in men and women. J Pain 5:264–9
Ross C, Davies P, Whitehouse W (2002) Melatonin treatment for sleep disorders in children with neurodevelopmental disorders: an observational study. Develop Med Child Neurol 44:339–44
Schlarb AA, Schwerdtle B, Hautzinger M (2010 Dec 1b) Validation and psychometric properties of the German version of the Children‘s Sleep Habits Questionnaire (CSHQ-DE). Somnologie 14:260–6
Schlarb AA, Schwerdtle B, Hautzinger M (2010 Dec 1a) Validation and psychometric properties of the German version of the Children‘s Sleep Habits Questionnaire (CSHQ-DE). Somnologie 14:260–6
Schlueter B (2009) SchlafStörungen im Kindes- und Jugendalter: Grundlagen, Diagnostik und Therapie. Pädiatr Prax 73:29–40
Schwerdtle B, Roeser K, K3bler A, Schlarb AA (2010 Dec 1) Validierung und psychometrische Eigenschaften der deutschen Version des Sleep Self Report (SSR-DE). Somnol Schlafforsch Schlafmed 14:267–74
Seddon PC, Khan Y (2003) Respiratory problems in children with neurological impairment. Arch Dis Child 88:75–8
Sheldon SH, Ferber R, Kryger MH (2005) Principles and practice of pediatric sleep medicine, Elsevier Saunders, Philadelphia
Shibagaki M, Kiyono S, Watanabe K (1982) Spindle evolution in normal and mentally retarded children: a review. Sleep 5:47–57
Stores G (1992) Annotation: sleep studies in children with a mental handicap. J Clin Child Psychol 33:1303–17
Stores G (1999) Sleep disorders in children and adolescents. Advanc Psychiatr Treat 5:19–29
Stores G, Wiggs L (eds) (2001a) Sleep disturbances in children and adolescents with disorders of development: its significance and management. Mac Keith Press, London
Stores G, Wiggs L (2001b) Sleep problems and sleep disorders. In: Stores G, Wiggs L (eds) Sleep disturbances in children and adolescents with disorders of development: its significance and management, 1st ed. Mac Keith Press, Oxford; pp 15–23
Stores G, Wiggs L, Campling G (1998) Sleep disorders and their relationship to psychological disturbance in children with epilepsy. Child Care Health Develop 24:5–19
Tietze AL, Blankenburg M, Hechler T, Michel E, Koh M, Schluter B et al. (2011) Sleep disturbances in children with multiple disabilities. Sleep Med Rev 16:117–27
Vgontzas MD, Kales MD (1999) Sleep and its disorders. Annu Rev Med 50:387–400
Weeß HG (2009) Diagnostische Methoden. In: Stuck BA, Mauerer JT, Schredl M, Weeß HG (Hrsg) Praxis der Schlafmedizin. Springer, Heidelberg New York Tokio; pp 23–78
Wiggs L, France K (2000) Behavioural treatments for sleep problems in children and adolescents with physical illness, psychological problems or intellectual disabilities. Sleep Med Rev 4:299–314
Wiggs L, Stores G (1996) Severe sleep disturbance and daytime challenging behaviour in children with severe learning disabilities. J Intellect Disabil Res 40:518–28
Zucconi M, Bruni O (2001) Sleep disorders in children with neurologic diseases. Elsevier, Philadelphia; pp 258–75
Abschnitt 6.2.9
Breitbart W, Alici Y (2008) Agitation and delirium at the end of life. JAMA 300:2898–910
Creten C, van der Zwaan S, Blankespoor R, Leroy PL, Schieveld JN (2011) Pediatric delirium in the pediatric intensive care unit: a systematic review and an update on key issues and research questions. Minerva Anestesiol 77:1099–107
Harrison AM, Lugo RA, Lee WE, Appachi E, Bourdakos D, Davis SJ et al. (2002) The use of haloperidol in agitated critically ill children. Clin Pediatr (Phila) 41:51–4
Leentjens AFG, Schieveld JNM, Leonard M, Lousberg R, Verhey FRJ, Meagher DJ (2008) A comparison of the phenomenology of pediatric, adult, and geriatric delirium. J Psychosom Res 64:219–23
Lipman AG, Jackson K, Tyler L (2000) Evidence Based Symptom Control in Palliative Care. Haworth Press, Binghampton, New York
Lonergan E, Britton AM, Luxenberg J, Wyller T (2007) Antipsychotics for delirium. Cochrane Database Syst Rev 2:CD005594
Remschmidt H, Schmidt M, Poustka F (Hrsg) (2006) Multiaxiales Klassifikationsschema für psychische Störungen des Kindes- und Jugendalters nach ICD-10 der WHO – Mit einem synoptischen Vergleich von ICD-10 und DSM-IV. Huber, Bern
Schieveld JNM (2011) On pediatric delirium and the use of the Pediatric Confusion Assessment Method for the Intensive Care Unit. Crit Care Med 39:220–1
Schieveld JNM, Van Der Valk JA, Smeets I, Berghmans E, Wassenberg R, Leroy PLMN et al. (2009) Diagnostic considerations regarding pediatric delirium: a review and a proposal for an algorithm for pediatric intensive care units. Intensive Care Med 35:1843–9
Smith HAB, Boyd J, Fuchs DC, Melvin K, Berry P, Shintani A et al. (2011) Diagnosing delirium in critically ill children: Validity and reliability of the Pediatric Confusion Assessment Method for the Intensive Care Unit. Crit Care Med 39:150
Stoddard FJ, Usher CT, Abrams AN (2006) Psychopharmacology in Pediatric critical care. Child Adolesc Psychiatr Clin N Am 15:611–55
Trzepacz P, Baker RW, Greenhouse J (1987) A symptom rating scale for delirium. Psychiatry Res 23:89–97
Turkel SB, Braslow K, Tavaré CJ, Trzepacz PT (2003) The Delirium Rating Scale in children and adolescents. Psychosomatics 44:126–9
Wusthoff CJ, Shellhaas RA, Licht DJ (2007) Management of Common Neurologic Symptoms in Pediatric Palliative Care: Seizures, Agitation, and Spasticity. Pediatr Clin North Am 54:709–33
Abschnitt 6.2.10
Binetti P (2003) The child confronting fear of death: the nurse as a secondary figure of attachment. Int Nurs Perspect 3:5–16
Bluebond-Langner M (1980) The private world of dying children, Princeton University Press, Princeton New York
Brown MR, Sourek B (2006) Psychotherapy in pediatric palliative care. Child Adolesc Psychiatr Clin N Am 15:585–96
Bürgin B (1981) Das Kind, die lebensbedrohende Krankheit und der Tod, Verlag Hans Huber, Bern
Delgado-Guay MO, Parsons HA, Li Z, Palmer JL, Bruera E (2009) Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer 17:573–9
Kersun LS, Shemesh E (2007) Depression and Anxiety in Children at the End of Life. Pediatr Clin North Am 54:691–708
Kolva E, Rosenfeld B, Pessin H, Breitbart W, Brescia R (2011) Anxiety in Terminally Ill Cancer Patients. J Pain Symptom Manage 42:691–701
Lipman AG, Jackson K, Tyler L. (2000) Evidence Based Symptom Control in Palliative Care. Haworth Press, Binghampton, New York
McCall JE, Fischer CG, Warden G, Kopcha R, Lloyd S, Young J, et al. (1999) Lorazepam given the night before surgery reduces preoperative anxiety in children undergoing reconstructive burn surgery. J Burn Care Res 20:151–4
Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interviewbased studies. Lancet Oncol 12:160–74
Patel D, Meakin G. (1997) Oral midazolam compared with diazepam-droperidol and trimeprazine as premedicants in children. Pediatric Anesthesia 7, 287-293.,
Remschmidt H, Schmidt M, Poustka F (Hrsg) (2006) Multiaxiales Klassifikationsschema für psychische Störungen des Kindes- und Jugendalters nach ICD-10 der WHO - Mit einem synoptischen vergleich von ICD-10 und DSM-IV. Remschmidt H, Schmidt M, Poustka F (Hrsg), Hans Huber, Bern
Siméon JG (1993) Use of anxiolytics in children. L’Encephale: Dialogues Clin Neurosci 19:71–4
Stoddard FJ, Usher CT, Abrams AN (2006) Psychopharmacology in Pediatric critical care. Child Adolesc Psychiatr Clin N Am 15:611–55
Zernikow B (2009) Schmerztherapie bei Kindern, Jugendlichen und jungen Erwachsenen. In: Zernikow B (Hrsg), Springer, Heidelberg
Abschnitt 6.2.11
Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA et al. (2007) Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment. JAMA 297:1683–96
Delgado-Guay MO, Parsons HA, Li Z, Palmer JL, Bruera E (2009) Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer 17:573–9
Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E et al. (2002) Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psych 41:1205–15
Hazell P, O‘Connell D, Heathcote D, Henry D (2002) Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev 2:CD002317
Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL (2004) Efficacy and safety of antidepressants for children and adolescents. BMJ 328:879–83
Kersun LS, Shemesh E (2007) Depression and Anxiety in Children at the End of Life. Pediatr Clin North Am 54:691–708
Lipman AG, Jackson K, Tyler L (2000) Evidence Based Symptom Control in Palliative Care. Haworth Press, Binghampton, New York
Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C et al. (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interviewbased studies. Lancet Oncol12;160–74
Rayner L, Price A, Evans A, Valsraj K, Hotopf M, Higginson IJ (2011a) Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliat Med 25:36–51
Rayner L, Price A, Hotopf M, Higginson IJ (2011b) The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur J Cancer 47:702–12
Remschmidt H, Schmidt M, Poustka F (Hrsg) (2006) Multiaxiales Klassifikationsschema für psychische Störungen des Kindes- und Jugendalters nach ICD-10 der WHO – Mit einem synoptischen Vergleich von ICD-10 und DSM-IV. Huber, Bern
Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RK (2007) Supportive care guidelines group of cancer care Ontario program in evidence-based care. The treatment of depression in cancer patients: A systematic review. Support Care Cancer 15:123–36
Rosenstein DL (2011) Depression and end-of-life care for patients with cancer. 13:101–8
Signer M (2012) Depression in palliative care. Ther Umsch 69:99–106
Stoddard FJ, Usher CT, Abrams AN (2006) Psychopharmacology in Pediatric critical care. Child Adolesc Psychiatr Clin N Am 15:611–55
Vitiello B, Swedo S (2004) Antidepressant medications in children. N Engl J Med 350:1489–91
Zu Abschnitt 6.3: Abschnitt 6.3.1
Anbar RD (2001) Self-hypnosis for the treatment of functional abdominal pain. Clin Pediatr (Phila) 40:447–51
Anbar RD, Linden JH (2010) Understanding Dissociation and Insight in the Treatment of Shortness of Breath with Hypnosis: A Case Study. Am J Clin Hypn 52:263–73
Bausewein C, Booth S, Gysels M, Higginson IJ (2008) Nonpharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane database of syst rev 16(2):CD005623
Ben-Aharon I, Gafter-Gvili A, Paul M, Leibovici L, Stemmer SM (2008 May 10) Interventions for Alleviating Cancer-Related Dyspnea: A Systematic Review. J Clin Oncol 26:2396–404
Cohen SP, Dawson TC (2002) Nebulized morphine as a treatment for dyspnea in a child with cystic fibrosis. Pediatr 110:e38
Duval M, Wood C (2002) Traitement des symptomes non douloureux chez l’enfant en fin de vie: Treatment of non-painful symptoms in terminally ill children. Arch Pediatr 9:1173–8
Galbraith S, Fagan P, Perkins P, Lynch A, Booth S (2010) Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage 39:831–8
Goldman A, Chir B (2000) Symptoms and suffering at the end of life in children with cancer [Letter to the editor]. N Engl J Med 342:1998–9
Graff GR, Stark JM, Grueber R (2004) Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient. Respiration 71:646–9
Grimbert D, Lubin O, De Monte M, None LV, Perrier M, Carre P et al. (2004) Dyspnee et aerosols de morphine dans les soins palliatifs du cancer broncho-pulmonaire. Rev Mal Respir 21:10911097
Hoffer FA, Hancock ML, Hinds PS, Oigbokie N, Rai SN, Rao B (2007) Pleurodesis for effusions in pediatric oncology patients at end of life. Pediatr Radiol 37:269–73
Janahi IA, Maciejewski SR, Teran JM, Oermann CM (2000) Inhaled morphine to relieve dyspnea in advanced cystic fibrosis lung disease. Pediatr Pulmonol 30:257–9
Jennings AL, Davies AN, Higgins JPT, Anzures-Cabrera J, Broadley KE (2001) Opioids for the palliation of breathlessness in advanced disease and terminal illness. status and date: Cochrane Database Sys Rev 4:CD002066
Shaw P, Agarwal R (2004) Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev 1:CD002916
Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C (2010) Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev 1:CD007354
Sitte T, Bausewein C (2008) Intranasal Fentanyl for episodic breathlessness. J Pain Symptom Manage 36:e3
Thomas S, Bausewein C, Higginson IJ, Booth S (2011) Breathlessness in cancer patients – Implications, management and challenges. Eur J Oncol Nurs 15, 459–469
Uronis HE, Currow DC, McCrory DC, Samsa GP, Abernethy AP (2008) Oxygen for relief of dyspnoea in mildly-or nonhypoxaemic patients with cancer: a systematic review and meta-analysis. Br J Cancer 98:294–9
Viola R, Kiteley C, Lloyd NS, Mackay JA, Wilson J, Wong RKS (2008) The management of dyspnea in cancer patients: a systematic review. Support Care Cancer 16:329–37
Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S et al. (2000) Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342:326–33
Yorke J, Moosavi SH, Shuldham C, Jones PW (2010) Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 65:21–6
Abschnitt 6.3.2
Alonso JC (2011) Pleural effusion in liver disease. Sem Resp Crit Care Med 31:698–705
Barnes NP, Hull J, Thomson AH (2005) Medical management of parapneumonic pleural disease. Pediatr Pulmonol 39:127–34
Chalhoub M, Harris K, Castellano M, Maroun R, Bourjeily G (2011) The use of the PleurX catheter in the management of nonmalignant pleural effusions. Chron Respir Dis 8:185–91
Chee A, Tremblay A (2011) The use of tunneled pleural catheters in the treatment of pleural effusions. Curr Opin Pulm Med 17:237
Frank W (2004) Diagnostisches Vorgehen beim Pleuraerguss Current Diagnostic Approach to Pleural Effusion. Pneumologie 58:777–90
Hoffer FA, Hancock ML, Hinds PS, Oigbokie N, Rai SN, Rao B (2007) Pleurodesis for effusions in pediatric oncology patients at end of life. Pediatr Radiol 37:269–73
Light RW (2010) Pleural effusion in pulmonary embolism. Sem Resp Crit Care Med 31:716–22
Porcel JM (2011) Pleural effusions from congestive heart failure. Sem Resp Crit Care Med 31:689–97
Shaw P, Agarwal R (2004) Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev 1:CD002916
Uzbeck MH, Almeida FA, Sarkiss MG, Morice RC, Jimenez CA, Eapen GA et al. (2010) Management of malignant pleural effusions. Adv Ther 27:334–47
http://ecog.dfci.harvard.edu/general/perf_stat.html. Abgerufen 17.02.2012
Abschnitt 6.3.3
[1] Chang AB, Glomb WB (2006) Guidelines for evaluating chronic cough in pediatrics. Chest 129:260S-83S
Committee on Drugs (1997 Jun 1) Use of Codeine- and Dextromethorphan- Containing Cough Remedies in Children. Pediatr 99:918–20
Dellon EP, Shores MD, Nelson KI, Wolfe J, Noah TL, Hanson LC (2010) Family caregiver perspectives on symptoms and treatments for patients dying from complications of cystic fibrosis. J Pain Symptom Manage 40:829–37
Doona M, Walsh D (1998) Benzonatate for opioid-resistant cough in advanced cancer. Palliat Med 12:55–8
Goldsobel AB, Chipps BE (2010) Cough in the pediatric population. J Pediatr 156:352–8
Hagen N, Temple WJ, Baker T (1994) Cough as a systemic manifestation of cancer. J Pain Symptom Manage 9:3–4
Homsi J, Walsh D, Nelson KA (2001) Important drugs for cough in advanced cancer. Support Care Cancer 9:565–74
Irwin RS, Curley FJ (1991) The treatment of cough. A comprehensive review. Chest 99:1477–84
Molassiotis A, Bailey C, Caress A, Brunton L, Smith J (2010) Interventions for cough in cancer. Cochrane Database of Syst Rev 9:CD007881
Morice AH, Menon MS, Mulrennan SA, Everett CF, Wright C, Jackson J et al. (2007) Opiate therapy in chronic cough. Am J Respir Crit Care Med 175:312–5
Moroni M, Porta C, Gualtieri G, Nastasi G, Tinelli C (1996) Inhaled sodium cromoglycate to treat cough in advanced lung cancer patients. Br J Cancer 74:309–11
Paul IM, Shaffer ML, Yoder KE, Sturgis SA, Baker MS, Berlin CM (2004) Dose-response relationship with increasing doses of dextromethorphan for children with cough. Clin Ther 26:1508–14
Stein WM, Min YK (1997) Nebulized morphine for paroxysmal cough and dyspnea in a nursing home resident with metastatic cancer. Am J Hosp Palliat Care 14:52
Udezue E (2001) Lidocaine inhalation for cough suppression. Am J Emerg Med 19:206–7
Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: Relationshipn to age, gender, and performance status in 1,000 patients. Supp Care Cancer 8:175–9
Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S et al. (2000) Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342:326–33
Zylicz Z, Krajnik M (2004) What has dry cough in common with pruritus? Treatment of dry cough with paroxetine. J Pain Symptom Manage 27:180–4
Abschnitt 6.3.4
Flume PA, Yankaskas JR, Ebeling M, Hulsey T, Clark LL (2005) Massive Hemoptysis in Cystic Fibrosis. Chest 128:729–38
Jean-Baptiste E (2000) Clinical assessment and management of massive hemoptysis. Crit Care Med 28:1642–7
Abschnitt 6.3.5
Bach JR (1994) Update and perspective on noninvasive respiratory muscle aids. Part 2: The expiratory aids. Chest 105:1538–44
Bickerman HA (1954) Exsufflation with Negative Pressure (EWNP). Elimination of radiopaque material and foreign bodies from bronchi of anesthetized dogs. Arch Intern Med 93:698
Guerin C, Bourdin G, Leray V, Delannoy B, Bayle F, Germain M et al. (2011) Performance of the cough assist insufflation-exsufflation device in the presence of an endotracheal tube or tracheostomy tube: a bench study. Respir Care 56:1108–14
Kang SW (2006) Pulmonary rehabilitation in patients with neuromuscular disease. Yonsei Med J 47:307
Liszner K, Feinberg M (2006) Cough assist strategy for pulmonary toileting in ventilator-dependent spinal cord injured patients. Rehabil nurs 31:218–21
Newth CJ, Amsler B, Anderson GP, Morley J (1991) The effects of varying inflation and deflation pressures on the maximal expiratory deflation flow-volume relationship in anesthetized rhesus monkeys. Am Rev Respir Dis 144:807–13
Zu Abschnitt 6.4: Abschnitt 6.4.1
Bajaj V, Langtry JAA (2007) Use of oral glycopyrronium bromide in hyperhidrosis. Br J Dermatol 157:118–21
Blaser G (2009) Erganzende, naturheilkundlich orientierte Pflege bei schmerzhaften Erkrankungen. In: Zernikow B (Hrsg) Schmerztherapie bei Kindern, Jugendlichen und jungen Erwachsenen, 4. Aufl. Springer, Berlin; S 396–419
Deaner PB (2000) The use of thalidomide in the management of severe sweating in patients with advanced malignancy: trial report. Palliat Med 14:429–31
Eisen TG (2000) Thalidomide in solid tumors: the London experience. Oncology-Huntington 14:17–20
Pittelkow MR, Loprinzi C (2004) Pruritus and Sweating in Palliative Medicine. In: Doyle D, Hanks G, Cherny N, Calman K (eds) Oxford Textbook of Palliative Medicine, 3rd ed. Oxford University Press, New York; pp 573–87
Quigley CS, Baines M (1997) Descriptive epidemiology of sweating in a hospice population. J Palliat Care 13:22–6
Tupker RA, Harmsze AM, Deneer VHM (2006) Oxybutynin therapy for generalized hyperhidrosis. Arch Dermatol 142:1065–86
Zhukovsky DS (2002) Fever and sweats in the patient with advanced cancer. Hematol Oncol Clin North Am 16:579–88
Abschnitt 6.4.2
DNQP (2009) Expertenstandard. Pflege von Menschen mit chronischen Wunden. Einschließlich Kommentierung und Literaturanalyse. In: Deutsches Netzwerk für Qualitätsentwicklung in der Pflege (Hrsg), Selbstverlag, Osnabrück
DNQP (2010) Expertenstandard. Dekubitusprophylaxe in der Pflege. In: Deutsches Netzwerk für Qualitätsentwicklung in der Pflege (Hrsg), Selbstverlag, Osnabruck
European Pressure Ulcer Advisory Panel (EPUAP) and National Pressure Ulcer Advisory Panel (NPUAP) (2009) Prevention and Treatment of pressure ulcers: Quick Reference Guide, National Pressure Advisory Pane, Washington DC
Institut für Innovation im Gesundheitswesen und angewandte Pflegeforschung e.V. (IGAP) (2011) Dekubitus Pflege-Ratgeber, http://www.dekubitus.de/dekubitus-entstehung.htm. Abgerufen 14.06.2011
Abschnitt 6.4.3
Uebach B, Kern M (2010) Wunden sind nicht immer heilbar – Palliative Wundversorgung exulzerierender Tumorwunden. Pallamed-Verlag, Bonn
Vanscheidt A, Ukat A (2007) Systematisches Management chronischer Wunden nach dem Time Prinzip. In: Wild T, Auböck J (Hrsg) Manual der Wundheilung. Springer, Wien
Abschnitt 6.4.4
Bausewein C, Roller S, Voltz R (2007) Leitfaden Palliativmedizin – Palliative Care, Urban & Fischer, München
Bigliardi PL, Stammer H, Jost G, Rufli T, Buchner S, Bigliardi-Qi M (2007) Treatment of pruritus with topically applied opiate receptor antagonist. J Am Acad Dermatol 56:979–88
Chabane N, Leboyer M, Mouren-Simeoni MC (2000) Opiate antagonists in children and adolescents. Eur Child Adolesc Psychiatry 9:44–50
Davis MP, Frandsen JL, Walsh D, Andresen S, Taylor S (2003) Mirtazapine for pruritus. J Pain Symptom Manage 25:288–91
Deshpande PV (2004) Ondansetron for paediatric uraemic pruritus: a case report. Pediatr Nephrol 19:694–6
Ehrchen J, Ständer S (2008) Pregabalin in the treatment of chronic pruritus. J Am Acad Dermatol 58:S36-S37
Gooding S, Canter PH, Coelho HF, Boddy K, Ernst E (2010) Systematic review of topical capsaicin in the treatment of pruritus. Int J Dermatol 49:858–65
Gunal AI, Ozalp G, Yoldas TK, Gunal SY, Kirciman E, Celiker H (2004) Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, doubleblind trial. Nephrol Dial Transplant 19:3137–9
Knipping C (2008) Lehrbuch Palliative Care. Huber, Bern
Krajnik M, Zylicz Z (2001) Understanding pruritus in systemic disease. J Pain Symptom Manage 21:151–68
Kupfer J, Keins P, Brosig B, Darsow U, Diepgen TL, Fartasch M et al. (2003) Development of questionnaires on coping with disease and itching cognitions for children and adolescents with atopic eczema. Dermatol Psychosom 4:79–85
Mansour-Ghanaei F, Taheri A, Froutan H, Ghofrani H, Nasiri-Toosi M, Bagherzadeh AH et al. (2006) Effect of oral naltrexone on pruritus in cholestatic patients. World J Gastroenterol 12:1125–8
Ständer S, Schmelz M (2006) Chronic itch and pain-similarities and differences. Eur J Pain 10:473–8
Trioche P, Samuel D, Odièvre M, Labrune P (1996) Ondansetron for pruritus in child with chronic cholestasis. Eur J Pediatr 155:990–96
Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, Szepietowski JC et al. (2003) Itch: scratching more than the surface. QJM 96:7–26
Wan KS (2009) Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria. J Dermatol Treat 20:194–7
http://awmf.org/uploads/tx_szleitlinien/013-048k_S2k_Chronischer_Pruritus_Version_2-1.pdf. Abgerufen 06.04.2012
Abschnitt 6.4.5
Buchhorn R, Krämer R (1998) Leitlinien zur rationellen Diagnostik und Therapie in der pädiatrischen Kardiologie; Chronische Herzinsuffizienz im Kindesalter. AWMFLeitlinien-Register Nr.023/006. http://www uni-duesseldorf de/AWMF/. Abgerufen 05.04.2012
Mehne S, Nieland P, Simader R (2007) Basiscurriculum Physiotherapie in Palliative Care Palliativmedizin und Hospizwesen. In: DGP Arbeitskreis Physiotherapie (Hrsg). Pallia Med Verlag, Bonn
WCPT (World Confederation for Physical Therapy) (2007) Ethische Grundsätze für PhysiotherapeutInnen. http://www.wcpt.org/node/29030. Abgerufen 20.03.2012
http://www.dgpalliativmedizin.de. Abgerufen 14.04.2012
Abschnitt 6.4.6
Arbeitsgemeinschaft Dermatologische Infektologie der Deutschen Dermatologischen Gesellschaft (2000) Leitlinie Zoster und Zosterschmerz. http://www.awmf.org. Abgerufen 07.04.2012
Bomgaars L, Thompson P, Berg S, Serabe B, Aleksic A, Blaney S (2008) Valacyclovir and acyclovir pharmacokinetics in immunocompromised children. Pediatric Blood & Cancer 51:504–8
Dekker CL, Prober CG (2001) Pediatric uses of valacyclovir, penciclovir and famciclovir. Pediatr Infect Dis J 20:1079–81
Donahue JG, Choo PW, Manson JAE, Platt R (1995) The incidence of herpes zoster. Arch Intern Med 155:1605
Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M et al. (2007) Recommendations for the management of herpes zoster. Clin Infect Dis 44:S1-S26
Eksborg S (2003) The pharmacokinetics of antiviral therapy in paediatric patients. Herpes: the journal of the IHMF 10:66–71
Feder Jr HM, Hoss DM (2004) Herpes zoster in otherwise healthy children. Pediatr Infect Dis J 23:451–7
Gershon AA, Mervish N, LaRussa P, Steinberg S, Lo SH, Hodes D et al. (1997) Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection. J Infect Dis 176:1496–500
Heidl M, Scholz H, Dörffel W, Hermann J (1991) Antiviral therapy of varicella-zoster virus infection in immunocompromised children-a prospective randomized study of aciclovir versus brivudin. Infection 19:401–5
Heininger U, Seward JF (2006) Varicella. Lancet 368:1365–76
Hope-Simpson RE (1975) Postherpetic neuralgia. JRColl Gen Pract 25:571
Leung TF, Chik KW, Li CK, Lai H, Shing MM, Chan PK et al. (2000) Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant 25:167
Ljungman P (2002) Prevention and treatment of viral infections in stem cell transplant recipients. Br J Haematol 118:44–57
Nadal D, Leverger G, Sokal EM, Floret D, Perel Y, Leibundgut K et al. (2002) An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children. J Infect Dis 186:S123-S130
Síez-Llorens X, Yogev R, Arguedas A, Rodriguez A, Spigarelli MG, Castrej, |n TDL et al. (2009) Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection. Antimicrob Agents Chemother 53:1912–20
Terada K, Kawano S, Yoshihiro K, Yokobayashi A, Miyashima H, Morita T (1993) Characteristics of herpes zoster in otherwise normal children. Pediatr Infect Dis J 12:960–1
Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ (2000) Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 9:863–99
Wassilew SW, Wutzler P (2003) Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia. Antiviral Res 59:57–60
Wutzler P, De Clercq E, Wutke K, Färber I (1995) Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: A randomized double-blind trial. J Med Virol 46:252–7
Zu Abschnitt 6.5: Abschnitt 6.5.1 bis 6.5.3
Ademokun A, Kaznica S, Deas S (2005) Home blood transfusion: a necessary service development. Transfus Med 15:219–22
Alt-Epping B, Sitte T, Nauck F, Radbruch L (2010) Sedierung in der Palliativmedizin: Leitlinie für den Einsatz sedierender Maßnahmen in der Palliativversorgung. Schmerz 24:1–12
Beardsmore S, Fitzmaurice N (2002) Palliative care in paediatric oncology. Eur J Cancer 38:1900–7
Benson K (2006) Home is where the heart is: do blood transfusions belong there too? Transfus Med Rev 20:218–29
Brook L, Vickers J, Pizer B (2003) Home platelet transfusion in pediatric oncology terminal care. Med Pediatr Oncol 40:249–51
Havet N, Morelle M, Remonnay R, Carrere MO (2012) Cancer patients‘ willingness to pay for blood transfusions at home: results from a contingent valuation study in a French cancer network. Eur J Health Econ 13:289–300
McClelland DBL (2007) Handbook of Transfusion Medicine. United Kingdom Blood Services, London
Solheim BG, Wesenberg F (2001) Rational use of blood products. Eur J Cancer 37:2421–5
Abschnitt 6.5.4
Bausewein C, Roller S, Voltz R (2007) Leitfaden Palliativmedizin – Palliative Care, Urban & Fischer Verlag/Elsevier GmbH, München
Dean A, Tuffin P (1997) Fibrinolytic inhibitors for cancer-associated bleeding problems. J Pain Symptom Manage 13:20–4
Green JG, Durham TM (1991) Application of INSTAT hemostat in the control of gingival hemorrhage in the patient with thrombocytopenia:: A case report. Oral Surg Oral Med Oral Pathol 71:27–30
Griska LB, Aghamohamadi AM, Marlowe FI, Gonzales CF (1981) Embolization of hemorrhage caused by carcinoma of the pharynx. Head Neck Surg 3:202–3
Jassal SS (2011) Basic symptom control in paediatric palliative care. The Rainbow Children‘s Hospice Guidelines., ACT, Bristol
O‘Halpin D, Legge D, MacErlean DP (1984) Therapeutic arterial embolisation: report of five years‘ experience. Clin Radiol 35:85–93
Zu Abschnitt 6.6: Abschnitt 6.6.1 bis 6.6.5
Bachmann H, Steuber C (2010) Kontinenzschulung im Kindesund Jugendalter (Grundlagenmanual). Manual für die standardisierte Diagnostik, Therapie und Schulung bei Kindern und Jugendlichen mit funktioneller Harninkontinenz. In: Konsensusgruppe Kontinenzschulung im Kindes- und Jugendalter (Hrsg). Pabst Science Publishers, Lengerich
Beetz R (2006) May we go on with antibacterial prophylaxis for urinary tract infections? Pediatr Nephrol 21:5–13
Beetz R, Bachmann H, Gatermann S, Keller H, Kuwertz-Bröking E, Misselwitz J et al. (2007) Harnwegsinfektionen im Säuglings- und Kindesalter. Konsensus-Empfehlungen zur Diagnostik, Therapie und Prophylaxe. Monatsschr Kinderheilkd 155:261–71
Chiang D, Ben-Meir D, Pout K, Dewan PA (2005) Management of post-operative bladder spasm. J Paediatr Child Health 41:56–8
De Vries CR, Freiha FS (1990) Hemorrhagic cystitis: a review. Jl Urolog 143:1–9
Hoberman A, Wald ER, Hickey RW, Baskin M, Charron M, Majd M et al. (1999) Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatr 104:79–86
Kuwertz-Bröking E, Brinkmann OA, Hertle L, Bulla M (1998) Hämaturie im Kindesalter. Pädiatr Prax 55:449
Lazzeri M, Beneforti P, Benaim G, Maggi CA, Lecci A, Turini D (1996) Intravesical capsaicin for treatment of severe bladder pain: a randomized placebo controlled study. J Urology 156:947–52
Leibovitz E (2006) The use of fluoroquinolones in children. Curr Opin Pediatr 18:64–70
Madersbacher H (1993) Neurogene Blasenentleerungsstörungen im Kindesalter. In: Sigel A (Hrsg) Kinderurologie, 1. Aufl. Springer, Heidelberg New York Tokio
McCoubrie R, Jeffrey D (2003) Intravesical diamorphine for bladder spasm. J Pain Symptom Manage 25:1–3
Park JM, Houck CS, Sethna NF, Sullivan LJ, Atala A, Borer JG et al. (2000) Ketorolac suppresses postoperative bladder spasms after pediatric ureteral reimplantation. Anesth Analg 91:11–5
Reinberg Y, Crocker J, Wolpert J, Vandersteen D (2003) Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tar trate in children with diurnal urinary incontinence. J Urology 169:317–9
Singh I, Laungani GB (1992) Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhage. Urology 40:227–9
Twycross R (2001) Urinary Symptom. In: Twycross R (Hrsg) Symptom management in advanced cancer. Radcliffe Medical Press, Oxon, UK
Zu Abschnitt 6.7: Abschnitt 6.7.1
Bruera E, MacMillan K, Kuehn N, Hanson J, MacDonald RN (1990) A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer 66:1279–82
Bruera E, Roca E, Cedaro L, Carraro S, Chacon R (1985) Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 69:751
Dy SM, Apostol CC (2010) Evidence-based approaches to other symptoms in advanced cancer. Cancer J 16:507
Dy SM, Lorenz KA, Naeim A, Sanati H, Walling A, Asch SM (2008) Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea. J Clin Oncol 26:3886–95
Gebbia V, Testa A, Gebbia N (1996) Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer. Br J Cancer 73:1576–80
Goldman A, Chir B (2000) Symptoms and suffering at the end of life in children with cancer [Letter to the editor]. N Engl J Med 342:1998–9
Hechler T, Blankenburg M, Friedrichsdorf S, Garske D, Hübner B, Menke A et al. (2008) Parents‘ perspective on symptoms, quality of life, characteristics of death and end-of-life decisions for children dying from cancer. Klin Pädiatr 220:166–74
Hinds PS, Hockenberry-Eaton M, Quargnenti A, May M, Burleson C, Gilger E et al. (1999) Fatigue in 7-to 12-year-old patients with cancer from the staff perspective: an exploratory study. Oncol Nurs Forum 26:37–45
Hockenberry-Eaton M, Hinds PS, Alcoser P, O‘Neill JB, Euell K, Howard V et al. (1998) Fatigue in children and adolescents with cancer. J Pediatr Oncol Nurs 15:172–82
Lipman AG, Jackson K, Tyler L (2000) Evidence Based Symptom Control in Palliative Care. Haworth Press, Binghampton New York
Metz CA, Robustelli Della Cuna G, Pellegrini A, Piazzi M (1989) Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: A placebo-controlled, multicenter study. Eur J Cancer Clin Oncol 25:1817–21
Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG (1974) Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer 33:1607–9
Oster MH, Enders SR, Samuels SJ, Cone LA, Hooton TM, Browder HP et al. (1994) Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med 121:400–8
Peuckmann-Post V, Elsner F, Krumm N, Trottenberg P, Radbruch L (2010) Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev:CD 006788
Popiela T, Lucchi R, Giongo F (1989) Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group. Eur J Cancer Clin Oncol 25:1823–9
Twycross RG, Guppy D (1985) Prednisolone in terminal breast and bronchogenic cancer. The Practitioner 229:57
Ullrich CK, Mayer OH (2007) Assessment and Management of Fatigue and Dyspnea in Pediatric Palliative Care. Pediatr Clin North Am54:735–56
Von Lützau P, Otto M, Hechler T, Metzing S, Wolfe J, Zernikow B (2012) Children dying from cancer: parents’ perspectives on symptoms, quality of life, characteristics of death and end-of-life decisions. J Palliat Care submitted
Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Sa- lem-Schatz S et al. (2000) Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342:326–33
Yee JD, Berde CB (1994) Dextroamphetamine or methylphenidate as adjuvants to opioid analgesia for adolescents with cancer. J Pain Symptom Manage 9:122–5
Abschnitt. 6.7.2
Chan TC, Evans SD, Clark RF (1997) Drug-induced hyperthermia. Crit Care Clin 13:785–808
Chang JC (1989) Neoplastic fever: a proposal for diagnosis. Arch Intern Med 149:1728–30
Halloran LL, Bernard DW (2004) Management of drug-induced hyperthermia. Curr Opin Pediatr 16:211
Homsi J, Walsh D, Panta R, Lagman R, Nelson KA, Longworth DL (2000) Infectious complications of advanced cancer. Support Care Cancer 8:487–92
Kallio R, Bloigu A, Surcel HM, Syrjälä H (2001) C-reactive protein and erythrocyte sedimentation rate in differential diagnosis between infections and neoplastic fever in patients with solid tumours and lymphomas. Support Care Cancer 9:124–8
Lorin MI (1999) Pathogenesis of fever and its treatment. In: Oski F (Hrsg) Oski’s Pediatrics: principles and practices. Lippincott Williams & Wilkins, Philadelphia; pp 848–50
Mayoral CE, Marino RV, Rosenfeld W, Greensher J (2000) Alternating antipyretics: is this an alternative? Pediatr 105:1009–12
Meremikwu M, Oyo-Ita A (2003) Physical methods for treating fever in children (Cochrane Review). Cochrane Database Syst Rev:CD004264
Oh DY, Kim JH, Kim DW, Im SA, Kim TY, Heo DS et al. (2006) Antibiotic use during the last days of life in cancer patients. Eur J of Cancer Care 15:74–9
Pasic S, Minic A, Djuric P, Micic D, Kuzmanovic M, Sarjanovic L, et al. (2006) Fever of unknown origin in 185 paediatric patients: A single-centre experience. Acta Paediatr 95:463–6
Pereira J, Watanabe S, Wolch G (1998) A retrospective review of the frequency of infections and patterns of antibiotic utilization on a palliative care unit. J Pain Symptom Manage 16:374–81
Reinbolt RE, Shenk AM, White PH, Navari RM (2005) Symptomatic treatment of infections in patients with advanced cancer receiving hospice care. J Pain Symptom Manage 30:175–82
Stiel S, Krumm N, Pestinger M, Lindena G, Nauck F, Ostgathe C et al. (2012) Antibiotics in palliative medicine – results from a prospective epidemiological investigation from the HOPE survey. Support Care Cancer 20:325–33
Vanderschueren S, Knockaert D, Adriaenssens T, Demey W, Durnez A, Blockmans D et al. (2003) From prolonged febrile illness to fever of unknown origin: the challenge continues. Arch Intern Med 163:1033–41
Vitetta L, Kenner D, Sali A (2000) Bacterial infections in terminally ill hospice patients. J Pain Symptom Manage 20:326–34
Walson PD, Galletta G, Chomilo F, Braden NJ, Sawyer LA, Scheinbaum ML (1992) Comparison of multidose ibuprofen and acetaminophen therapy in febrile children. Arch Pediatr Adoles Med 146:626
White PH, Kuhlenschmidt HL, Vancura BG, Navari RM (2003) Antimicrobial use in patients with advanced cancer receiving hospice care. J Pain Symptom Manage 25:438–43
Zu Abschnitt 6.8
Andrews BT, Hammer GB (1997) Pediatric Neurosurgical Intensive Care. American Association of Neurological Surgeons, Parkridge, Illinois
Appleton R, MacLeod S, Martland T (2008) Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev 3:CD001905
Breitbart W, Alici Y (2008) Agitation and delirium at the end of life. JAMA 300:2898–910
Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C et al. (1996) A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153:231
Burke AL, Diamond PL, Hulbert J, Yeatman J, Farr EA (1991) Terminal restlessness – its management and the role of midazolam. Med J Autral 155:485–7
Bush SH, Bruera E (2009) The assessment and management of delirium in cancer patients. Oncologist 14:1039–49
Ch‘ien LT, Kalwinsky DK, Peterson G, Pratt CB, Murphy SB, Hayes F et al. (1982) Metastatic epidural tumors in children. Med Pediatr Oncol 10:455–62
Clines GA, Guise TA, Clines GA, Guise TA (2008) Molecular mechanisms and treatment of bone metastasis. Expert Rev Mol Med 10:e7
Cocito L, Audenino D, Primavera A, DeAngelis LM, Tuma R (2001) Altered mental state and nonconvulsive status epilepticus in patients with cancer. Arch Neurol 58:1310–2
Cvitkovic F, Armand JP, Tubiana-Hulin M, Rossi JF, Warrell Jr RP (2006) Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia. Cancer J 12:47
Dellon EP, Shores MD, Nelson KI, Wolfe J, Noah TL, Hanson LC (2010) Family caregiver perspectives on symptoms and treatments for patients dying from complications of cystic fibrosis. J Pain Symptom Manage 40:829–37
Desforges JF, Byrne TN (1992) Spinal cord compression from epidural metastases. N Engl J Med 327:614–9
Droney J, Hall E (2008) Status epilepticus in a hospice inpatient setting. J Pain Symptom Manage 36:97–105
Duval M, Wood C (2002) Traitement des symptomes non douloureux chez l’enfant en fin de vie: Treatment of non-painful symptoms in terminally ill children. Arch Pediatr 9:1173–8
Ely E, Stephens RK, Jackson JC, Thomason JWW, Truman B, Gordon S et al. (2004) Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: A survey of 912 healthcare professionals*. Crit Care Med 32:106–12
Fainsinger R, Miller MJ, Bruera E (1991) Symptom control during the last week of life on a palliative care unit. J Palliat Care 7:5–11
Feddersen B, Trinka E (2012) Status epilepticus. Nervenarzt 2:187–94
Ferrari LR, Bedford RF (1990) General anesthesia prior to treatment of anterior mediastinal masses in pediatric cancer patients. Anesthesiology 72:991–5
Fowell A, Stuart NSA (2007) Palliative care emergencies. Foundation Years 3:26–30
Frühwald MC, Rutkowski S (2011) Tumors of the central nervous system in children and adolescents. Dt Arztebl Int 108:390–7
Gagnon B, Mancini I, Pereira J, Bruera E (1998) Palliative management of bleeding events in advanced cancer patients. J Palliat Care 14:50–4
Gemlo B, Rayner AA, Lewis B, Wong A, Viele CS, Ungaretti JR et al. (1986) Home support of patients with end-stage malignant bowel obstruction using hydration and venting gastrostomy. Am J Surgery 152:100–4
Golf M, Paice JA, Feulner E, O’Leary C, Marcotte S, Mulcahy M (2004) Refractory status epilepticus. J Pall Med 7:85–8
Graeff AD, Dean M (2007) Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Pall Med 10:67–85
Gupta V, Ambati SR, Pant P, Bhatia B (2008) Superior vena cava syndrome in children. Ind J Hematol Blood Trans 24:28–30
Harris DG, Noble SIR (2009) Management of terminal hemorrhage in patients with advanced cancer: a systematic literature review. J Pain Symptom Manage 38:913–27
Ingram L, Rivera GK, Shapiro DN (1990) Superior vena cava syndrome associated with childhood malignancy: analysis of 24 cases. Med Pediatr Oncol 18:476–81
Inukai T, Hirose K, Inaba T, Kurosawa H, Hama A, Inada H et al. (2006) Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormonerelated peptide and E2A-HLF from translocation 17; 19. Leukemia 21:288–96
Jalmsell L, Kreicbergs U, Onelöv E, Steineck G, Henter JI (2006) Symptoms affecting children with malignancies during the last month of life: A nationwide follow-up. Pediatr 117:1314–20
Kato A, Ushio Y, Hayakawa T, Yamada K, Ikeda H, Mogami H (1985) Circulatory disturbance of the spinal cord with epidural neoplasm in rats. J Neurosurg 63:260–5
Kerdudo C, Aerts I, Fattet S, Chevret L, Pacquement H, Doz F et al. (2005) Hypercalcemia and childhood cancer: a 7-year experience. J Pediatr Hematol Oncol 27:23
Laval G, Girardier J, Lassauniere JM, Leduc B, Haond C, Schaerer R (2000) The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction? Palliat Med 14:3–10
Le Grand SB, Leskuski D, Zama I (2008) Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Ann Intern Med 149:259–63
Lewis DW, Packer RJ, Raney B, Rak IW, Belasco J, Lange B (1986) Incidence, presentation, and outcome of spinal cord disease in children with systemic cancer. Pediatr 78:438–43
Lonardi F, Gioga G, Agus G, Coeli M, Campostrini F (2002) Double-flash, large-fraction radiation therapy as palliative treatment of malignant superior vena cava syndrome in the elderly. Support Care Cancer 10:156–60
Lorenzl S, Mayer S, Noachtar S, Borasio GD (2008) Nonconvulsive status epilepticus in terminally Ill patients. GCoA diagnostic and therapeutic challenge. J Pain Symptom Manage 36:200–5
Lowenstein DH, Bleck T, Macdonald RL (1999) It’s time to revise the definition of status epilepticus. Epilepsia 40:120–2
Majumdar G (2002) Incidence and prognostic significance of hypercalcaemia in B-cell non-Hodgkin’s lymphoma. J Clin Pathol 55:637–8
Maldonado JR (2008a) Delirium in the acute care setting: characteristics, diagnosis and treatment. Crit Care Clin 24:657–722
Maldonado JR (2008b) Pathoetiological model of delirium: a comprehensive understanding of the neurobiology of delirium and an evidence-based approach to prevention and treatment. Crit Care Clin 24:789–856
Manes G, de Bellis M, Fuccio L, Repici A, Masci E, Ardizzone S et al. (2011) Endoscopic palliation in patients with incurable malignant colorectal obstruction by means of selfexpanding metal stent: analysis of results and predictors of outcomes in a large multicenter series. Arch Surg 146:1157
Mathur M, Sykes JA, Saxena VR, Rao SP, Goldman GM (2003) Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin. Pediatr Crit Care Medi 4:252
McMullan J, Sasson C, Pancioli A, Silbergleit R (2010) Midazolam versus Diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis. Acad Emerg Med 17:575–82
Mehta V, Singhi P, Singhi S (2007) Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. J Child Neurol 22:1191–7
Nauck F, Alt-Epping B (2008) Crises in palliative care - a comprehensive approach. Lancet Oncol 9:1086–91
O’Brien RT, Matlak ME, Condon VR, Johnson DG (1981) Superior vena cava syndrome in children. West J Med 135:143–7
Oudkerk M, Kuijpers T, Schmitz P, Loosveld O, de Wit R (1996) Self-expanding metal stents for palliative treatment of superior vena caval syndrome. Cardiovasc Intervent Radiol 19:146–51
Pereira J, Phan T (2004) Management of bleeding in patients with advanced cancer. Oncologist 9:561–70
Pritchard M, Burghen E, Srivastava DK, Okuma J, Anderson L, Powell B et al. (2008) Cancer-related symptoms most concerning to parents during the last week and last day of their child’s life. Pediatr 121:e1301-e1309
Ratcliff SL, Meyer III WJ, Cuervo LJ, Villarreal C, Thomas CR, Herndon DN (2004) The use of haloperidol and associated complications in the agitated, acutely ill pediatric burn patient. J Burn Care Res 25:472–8
Ripamonti C (1994) Management of bowel obstruction in advanced cancer. Curr Opin Oncol 6:351
Roberts SB, Coyne PJ, Smith TJ, Lyckholm LJ (2010) Palliative Use of Aminocaproic Acid to Control Upper Gastrointestinal Bleeding. J Pain Symptom Manage 40:e1-e3
Schieveld JNM, Leroy PLJM, van Os J, Nicolai J, Vos GD, Leentjens AFG (2007) Pediatric delirium in critical illness: phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unit. Intensive Care Med 33:1033–40
Sofou K, Kristjánsdóttir R, Papachatzakis NE, Ahmadzadeh A, Uvebrant P (2009) Management of prolonged seizures and status epilepticus in childhood: a systematic review. J Child Neurol 24:918–26
Stenekes SJ, Hughes A, Gr+®goire MC, Frager G, Robinson WM, McGrath PJ (2009) Frequency and self-management of pain, dyspnea, and cough in cystic fibrosis. J Pain Symptom Manage 38:837–48
Theunissen JM, Hoogerbrugge PM, van Achterberg T, Prins JB, Vernooij-Dassen MJ, Van Den Ende CH (2007) Symptoms in the palliative phase of children with cancer. Pediatr Blood Cancer 49:160–5
Trehan A, Cheetham T, Bailey S (2009) Hypercalcemia in acute lymphoblastic leukemia: an overview. J Pediatr Hematol Oncol 31:424
Twycross RG, Töller CS, Wilcock A, Stark C (2009) Symptom Management in Advanced Cancer, Palliativedrugs.com, Limited, Nottingham
Watanabe H, Inoue Y, Uchida K, Okugawa Y, Hiro J, Ojima E et al. (2007) Octreotide improved the quality of life in a child with malignant bowel obstruction caused by peritoneal dissemination of colon cancer. J Pediatr Surg 42:259–60
Wiese C, Ittner KP, Graf B, Lassen C (2012) Präklinische palliative Nötfalle – Besonderheiten bei der therapeutischen Entscheidung. Palliativmedizin 13:77–90
Wiese CHR, Nauck F, Graf BM, Hanekop GG (2010) Notarztliche Betreuung kinderpalliativmedizinischer Notfallsituationen – ein Problem für den Rettungsdienst? – Eine retrospektive, multizentrische Beobachtungsstudie. Z Evid Fortbild Qual Gesundhwes 104:143–9
Wimalawansa SJ (1994) Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate. Cancer 73:2223–30
Wisneski LA (1990) Salmon calcitonin in the acute management of hypercalcemia. Calcif Tissue Int 46:26–30
Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S et al. (2000) Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342:326–33
Wolfe J, Hammel JF, Edwards KE, Duncan J, Comeau M, Breyer J et al. (2008) Easing of suffering in children with cancer at the end of life: Is care changing? J Clin Oncol 26:1717
Yoong M, Chin RFM, Scott RC (2009) Management of convulsive status epilepticus in children. Arch Dis Child Educ Pract Ed 94:1–9
Zu Abschnitt 6.9
Cohen-Gogo S, Marioni G, Laurent S, Gaspar N, Semeraro M, Gabolde M et al. (2011) End of life care in adolescents and young adults with cancer: Experience of the adolescent unit of the Institut Gustave Roussy. Eur J Cancer 47:2735–41
Hendricks-Ferguson V (2008) Physical symptoms of children receiving pediatric hospice care at home during the last week of life. Oncol Nurs Forum 35:108–15
Ho C, Straatman L (2012) A review of pediatric palliative care service utilization in children with a progressive neuromuscular disease who died on a palliative care program. J Child Neurol, epub ahead of print
Kaleko M (2008) Memento. In: Kaléko M (Hrsg) Verse für Zeitgenossen, 23. Aufl. Rowohlt, Reinbek
Kreicbergs U, Lannen P, Onelöv E, Wolfe J (2007) Parental grief after losing a child to cancer: Impact of professional and social support on long-term outcomes. J Clin Oncol 25:3307–12
Kreicbergs U, Valdimarsdottir U, Onelöv E, Björk O, Steineck G, Henter JI (2005) Care-related distress. A nationwide study of parents who lost their child to cancer. J Clin Oncol 23:9162–71
McCarthy MC, Clarke NE, Ting CL, Conroy R, Anderson VA, Heath JA (2010) Prevalence and predictors of parental grief and depression after the death of a child from cancer. J Pall Med 13:8–31
Pritchard M, Burghen EA, Gattuso JS, West NK, Gajjar P, Srivastava DK et al. (2010) Factors that distinguish symptoms of most concern to parents from other symptoms of dying children. J Pain Symptom Manage 39:627–36
Pritchard M, Burghen E, Srivastava DK, Okuma J, Anderson L, Powell B et al. (2008) Cancer-related symptoms most concerning to parents during the last week and last day of their child’s life. Pediatr 121:e1301-e1309
Surkan PJ, Dickman PW, Steineck G, Onelöv E, Kreicbergs U (2006) Home care of a child dying of malignancy and parental awareness of a child’s impending death. Palliat Med 20:161–9
Von Lützau P, Otto M, Hechler T, Metzing S, Wolfe J, Zernikow B (2012) Children dying from cancer: parents’ perspectives on symptoms, quality of life, characteristics of death and end-of-life decisions. J Palliat Care, in press
Wolfe J, Hammel JF, Edwards KE, Duncan J, Comeau M, Breyer J et al. (2008) Easing of suffering in children with cancer at the end of life: Is care changing? J Clin Oncol 26:1717
Zu Abschnitt 6.10
Allonso-Babarro A, Varela-Cerdeira M, Torres-Vigil I, Rodriguez-Barrientos R, Bruera E (2010) At-home palliative sedation for end-of-life cancer patients. Palliat Med 24:486–92
Alt-Epping B, Sitte T, Nauck F, Radbruch L (2010) Sedierung in der Palliativmedizin: Leitlinie für den Einsatz sedierender Masnahmen in der Palliativversorgung. Schmerz 24:1–12
De Graeff A; Dean M (2007) Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Pall Med 10:67–85
Dussel V, Joffe S, Hilden JM, Watterson-Schaeffer J, Weeks JC, Wolfe J (2010) Considerations About Hastening Death Among Parents of Children Who Die of Cancer. Arch Pediatr Adolesc Med 164:231–7
Enck RE (1991) Drug-induced terminal sedation for symptom control. Am J Hosp Palliat Care 8:3–5
Goncalves F, Bento MJ, Alvarenga M, Costa I, Costa L (2008) Validation of a Consciousness Level Scale for Palliative Care. Palliat Med 22:724–9
Heath JA, Clarke NE, McCarthy M, Donath SM, Anderson VA, Wolfe J (2009) Quality of care at the end of life in children with cancer. J Paediatr Child Health 45:656–9
Hechler T, Blankenburg M, Friedrichsdorf S, Garske D, Hübner B, Menke A et al. (2008) Parents‘ perspective on symptoms, quality of life, characteristics of death and end-oflife decisions for children dying from cancer. Klin Pädiatr 220:166–74
James H, Trauner D (1985) The Glasgow Coma Scale. In: James H (ed) Brain insults in infants and children. Grune and Stratton, New York
Kovacs J, Casey N, Weixler D (2008) Palliative Sedierungstherapie in der Pädiatrie. WMW Wiener Medizinische Wochenschrift 158:659–63
Materstvedt LJ, Bosshard G (2009) Deep and continuous palliative sedation (terminal sedation): clinical-ethical and philosophical aspects. Lancet Oncol 10:622–7
Materstvedt LJ, Kaasa S (2000) Is terminal sedation active euthanasia? Tidsskrift for den Norske lägeforening: tidsskrift for praktisk medicin, ny räkke 120:1763–8
McWilliams LA, Holmberg D (2010) Adult attachment and pain catastrophizing for self and significant other. Pain 149:278–83
Ramsay MAE, Savege TM, Simpson BRJ, Goodwin R (1974) Controlled sedation with alphaxalone-alphadolone. Br Med J 2:656–9
Recommandations de la SFAP (2009) La sédation pour détresse en phase terminale et dans des situations spécifiques et complexes. http://www.sfaporg/content/guides-recommandations. Abgerufen 10.04.2012
Rosengarten OS, Lamed Y, Zisling T, Feigin A, Jacobs JM (2009) Palliative sedation at home. J Palliat Care 25:5
Stiel S, Krumm N, Schroers O, Radbruch L, Elsner F (2008) Indications and use of benzodiazepines in a palliative care unit. Schmerz (Berlin, Germany) 22:665
Teasdale G, Jennett B (1974) Assessment of coma and impaired consciousness: A practical scale. Lancet 304:81–4
Tobias JD (1997) Seizure after overdose of tramadol. South Med J 90:826–7
Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S et al. (2000) Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342:326–33
Zu Abschnitt 6.11
Ellershaw J, Foster A, Murphy D, Shea T, Overill S (1997) Developing an integrated care pathway for the dying patient. Eur J Pall Care 4:203–7
Zu Abschnitt 6.12: Abschnitt 6.12.1
Bachmann S, Längler A (2005) Hausmittel in der modernen Medizin, 1. Aufl. Elsevier, München
Ezzo J, Vickers A, Richardson MA, Allen C, Dibble SL, Issell B et al. (2005) Acupuncture-point stimulation for chemotherapyinduced nausea and vomiting. J Clin Oncol 23:7188–98
Fellowes D, Barnes K, Wilkinson S (2004) Aromatherapy and massage for symptom relief in patients with cancer. Cochrane Library Syst Rev:CD002287
Kiene H (2005) Was ist Cognition-based Medicine. Z Arztl Fortbild Qual Gesundh wes 99:301–6
Kienle GS, Kiene H (2011) Clinical judgement and the medical profession. J Eval Clin Pract 17:621–7
Laengler A, Spix C, Seifert G, Gottschling S, Graf N, Kaatsch P (2008) Complementary and alternative treatment methods in children with cancer: A population-based retrospective survey on the prevalence of use in Germany. Eur J Cancer 44:2233–40
Längler A, Spix C, Edelhauser F, Kameda G, Kaatsch P, Seifert G (2011) Use of homeopathy in pediatric oncology in Germany. Evidence-based complementary and alternative medicine: eCAM 2011
Längler A, Spix C, Edelhauser F, Martin DD, Kameda G, Kaatsch P et al. (2010) Anthroposophic medicine in paediatric oncology in Germany: Results of a population-based retrospective parental survey. Pediatr Blood Cancer 55:1111–7
Lim A, Cranswick N, South M (2011) Adverse events associated with the use of complementary and alternative medicine in children. Arch Dis Child 96:297–300
Paisley MA, Kang TI, Insogna IG, Rheingold SR (2011) Complementary and alternative therapy use in pediatric oncology patients with failure of frontline chemotherapy. Pediatr Blood Cancer 56:1088–91
Sackett DL, Rosenberg W, Gray JA, Haynes RB, Richardson WS (1996) Evidence based medicine: what it is and what it isn‘t. BMJ 312:71–2
Seifert G, Henze G, Längler A (2011) Adverse events associated with the use of complementary and alternative medicine in children. Arch Dis Child 96:786–7
Tomlinson D, Hesser T, Ethier MC, Sung L (2011) Complementary and alternative medicine use in pediatric cancer reported during palliative phase of disease. Support Care Cancer 19:1857–63
Abschnitt 6.12.2
Bachmann S, Längler A (2005) Hausmittel in der modernen Medizin. Elsevier, München
Baumler S (2007) Heilpflanzenpraxis heute. Elsevier, München
Brumm V, Ducommun-Capponi M (2012) Wickel und Kompressen. AT-Verlag, Aarau/Schweiz
Bühring U (2011) Praxis-Lehrbuch der modernen Heilpflanzenkunde. Sonntag, Stuttgart
Fingado M (2012) Therapeutische Wickel und Kompressen: Handbuch aus der Ita Wegman Klinik. Verlag am Goetheanum, Dornach/Schweiz
Fintelmann V, Weiss RF (2006) Lehrbuch der Phytotherapie. Hippokrates, Stuttgart
Price S, Price L (2009) Aromatherapie. Huber, Bern
Schilcher H, Dorsch W (2006) Phytotherapie in der Kinderheilkunde: Handbuch für Ärzte und Apotheker. Wissenschaftliche Verlagsgesellschaft, Stuttgart
Schönau E, Naumann EG, Längler A, Beuth J (2005) Pädiatrie integrativ. Elsevier, München
Sonn A, Baumgärtner U, Merk B (2010) Pflegepraxis: Wickel und Auflagen: Alternative Pflegemethoden erfolgreich anwenden. Thieme, Stuttgart
Sonn A, Bühring U (2004) Heilpflanzen in der Pflege. Huber, Bern
Thüler M (1998) Wohltuende Wickel. Maya Thüler, Bern
Werner B, von Braunschweig R (2011) Praxis Aromatherapie. Haug, Stuttgart
Wichtel M (2008) Teedrogen und Phytopharmaka. Wissenschaftliche Verlagsgesellschaft, Stuttgart
Zimmermann E (2011) Aromatherapie für Pflege- und Heilberufe: Kursbuch für Ausbildung und Praxis. Sonntag, Stuttgart
Abschnitt 6.12.3
Fröhlich A (1998) Basale Stimulation in der Pflege. Verlag Selbstbestimmtes Leben, Düsseldorf
jjAbschnitt 6.12.4
Haus R (2003a) Der Einsatz der schöpferischen Musiktherapie nach Nordhoff/Robbins in der pädiatrischen Onkologie. In: Kiess W (Hrsg) Kinder- und Jugendmedizin, Bd 1. Schattauer, Stuttgart
Haus R (2003b) Musiktherapie bei Frühgeborenen. Gesellschaft für Perinatale Medizin Gu N (ed). Thieme, Stuttgart
Haus R (2004a) Musik hilft krebskranken Kindern. Theorie Prax Sozialpäd 7
Haus R (2004b) Musiktherapie bei langzeitbeatmeten Kindern. In: Gesellschaft für Orff-Musiktherapie (Hrsg) Tagungsband Symposium Entwicklungsperspektiven. Eigenverlag, Hamburg
Nordoff P, Robbins C (1986) Schopferische Musiktherapie. In: Bolay V, Bernius V (Hrsg) Praxis der Musiktherapie, Bd 3. Fischer, Stuttgart
Abschnitt 6.12.5
Franzke E (1989) Der Mensch und sein Gestaltungserleben: Psychotherapeutische Nutzung kreativer Arbeitsweisen. Huber, Bern Stuttgart Toronto
Leuteritz A (1993) Rezeptive Kunsttherapie. In: von Baukus J, von Baukus P (Hrsg) Aktuelle Tendenzen in der Kunsttherapie. Thiers, Stuttgart Jena New York
Mechler-Schönach C (2005) InSzene Kunsttherapie. In: von Spreti F, Martius P, Förstl H (Hrsg) Kunsttherapie bei psychischen Störungen. Elsevier, München
Menzen KH (2009) Grundlagen der Kunsttherapie. UTB, München
Ott GH (1993) Bildende Kunst in der Medizin. In: von Baukus J, von Baukus P (Hrsg) Aktuelle Tendenzen in der Kunsttherapie. Thiers, Stuttgart Jena New York
Schottenloher G (1992) Kunst- und Gestaltungstheorie. Kösel, München
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zernikow, B. (2013). Symptomerfassung und -therapie. In: Zernikow, B. (eds) Palliativversorgung von Kindern, Jugendlichen und jungen Erwachsenen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29610-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-29610-9_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-29609-3
Online ISBN: 978-3-642-29610-9
eBook Packages: Medicine (German Language)